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The following introduction is divided into three sections. The first section clarifies the term 
‘informal caregiver’, illustrates the role of caregivers and describes consequences of 
caregiving (1.1). In the second part, instruments that measure effects of caregiving are 
outlined and exemplified by the Zarit Burden Interview (1.2). The last section describes 
interventions for caregivers and elucidates mindfulness-based interventions through the 
example of Existential Behavioural Therapy and its short-term version (1.3). 
1.1 Caregivers of palliative patients 
Palliative care, as defined by the World Health Organisation (WHO), aims to treat the 
symptoms of patients who suffer from diseases and conditions which are potentially life 
threatening.[1] While worldwide an estimate of 40 million people need palliative care every 
year, only around 14 % have access to it and as chronic diseases are increasing and 
populations are aging, the need for palliative care is predicted to grow even further.[2] 
Providing adequate palliative care is a challenging task for national health systems. In a 
ranking of countries on the basis of their integration of hospice and palliative care services 
into mainstream health service provision, Germany is ranked in the top group of countries 
with advanced integration.[3] Since 2007, every health insurant in Germany is legally entitled 
to receive specialised palliative care.[4] According to the German Association for Palliative 
Medicine there were 345 palliative care wards in Germany in 2019.[5] Due to the life-
threatening condition, both patients and their families can be faced with physical, 
psychosocial or spiritual difficulty.[2] Therefore, the WHO defined that the aim of palliative 
care is to improve the quality of life of not only palliative patients and but also of their 
families.[1] This includes providing emotional support during the illness and for the 
bereaved [1] – a remarkable aspect of this branch of medicine, as it means to expand care to 
the caregiver and to provide support even after the patient has passed away.  
The term “caregiver” has a variety of meanings. The subject matter of the publications 
included in this thesis are informal caregivers1. In contrast to nursing staff in hospitals and 
staff of out-patient nursing services, informal caregivers can be defined by not being 
financially rewarded for the care they provide.[6] They can be family members or people who 
are not related to the patient, such as friends or neighbours. Informal caregivers often 
unexpectedly take over responsibilities due to the poor health of another person. One way to 
 





become the informal caregiver of a patient is being given power of attorney by the patient. 
This is usually documented in the living will or in an advance health care directive of a 
patient. If the patient has made no such provision, informal caregivers can be installed as legal 
guardians by court. When the patient is admitted to hospital, caregivers can be named as 
emergency contact, which is often the only information about a caregiver available to hospital 
staff. The caregiver listed could not only be contacted in case of emergency but also by social 
services when planning the discharge. Helping the hospital staff with discharge planning is 
one of a variety of caregivers’ potential responsibilities, which include financial procuration, 
health care decision making, taking care of the patient’s home, children or pets, visiting or 
offering emotional support for the patient.  
By taking over responsibility for the patient, caregivers support the medical treatment of a 
patient, they are “key partners” [7] to the health care system. Many care situations are 
possible only due to caregivers’ efforts [8]: A lot of palliative patients wish to die at home [9] 
and this wish can only be granted when caregivers are able and willing to organise the 
professional treatment of patients at home. Caregivers can slip out of focus as a palliative care 
team’s task of treating the patient can be time consuming. Overseeing caregivers, however, 
and not including them in treatment decisions can reduce the adequacy of the treatment: 
While the professional team bring their expertise to the table, only caregivers know about 
factors in the home environment, which could improve the care or which might put the 
patient’s care at risk. Caregivers’ own instability might be a reason for refraining from 
discharging a patient to the home setting. 
The concept of “total pain” introduced by Cicely Saunders [10], the founder of the modern 
hospice movement, can serve as a guideline to palliative care and raises awareness to the 
different facets of struggles a patient can face. “Total pain” includes a person's physical, 
psychological, spiritual, practical and social struggles [10], which also comprises the 
importance of social relations, such as relationships with caregivers. The implementation of 
the “total pain” concept should raise awareness for the physical and mental state of patients’ 
caregivers. When patients are distressed, it is likely that caregivers are distressed – and vice 
versa.[11] 
Some studies described positive aspects of caregiving and cited caregivers who reported that 
caregiving had a positive impact on their relationships, increased their wellbeing and gave 





predictors of positive outcomes may identify caregivers who are less likely to need 
support.[13]  
However, studies on positive aspects of caregiving are rare and majority of studies on 
effects of caregiving focus on negative aspects and several negative effects of caregiving 
have been found.[14, 15] Especially palliative caregivers are affected, as results of a study 
show, in which end-of-life caregivers were compared to short-term and long-term caregivers. 
The authors found that caregiving at the end of life is probably the most intense type of 
caregiving and potentially causes the highest caregiver burden.[7] 
A recent retrospective study showed a prevalence of psychological morbidity for end-of-life 
caregivers of 83% compared to 15% in the general population.[16] Previous studies had 
already found that, compared to the general population, caregivers have an increased risk for 
anxiety [17] and depression [18], lower quality of life [19] and higher mortality even [20]. 
Adverse effects of caregiving have been found to increase progressively with the number of 
hours devoted to care.[21] Reasons for adverse effects may be that caregivers have neither the 
time, nor the ability, the knowledge or the resources to maintain their own health and quality 
of life while taking care of another person.[7] The concept of learned helplessness, developed 
by Seligman [22] could also explain adverse psychological effects of caregiving. According 
to Seligman’s theory, people who perceive events as uncontrollable will develop the belief of 
being helpless which can promote the development of mental disorders. Caregivers could 
regard the terminal illness of the patient as uncontrollable because they have no influence on 
the progression of the disease or on the effects of therapies. This could lead to helplessness, 
resignation and symptoms of depression or anxiety.[22] 
While findings on psychological health are rather consistent, differences of physical health 
between caregivers and the general population are less unanimous. In some studies, caregivers 
report worse mental and physical health than the general population.[23, 24] Other studies 
show that caregivers of patients staying at home have better or similar physical health than 
non-caregivers.[17, 25] A reason for this might be self-selection, resulting in only physically 
healthy caregivers shouldering the burden of homecare.  
Caregiving can also interfere with caregivers’ paid work. Some caregivers take unpaid leave 
which can lead to in financial difficulties, they could miss out on career opportunities or even 





the choice between caregiving and professional pursuits.[27] Additionally, job insecurity is 
highly associated with poorer mental health.[28] 
1.2 Measuring effects of caregiving 
Concepts of mental disorders and their specific symptoms are results of psychological 
research. Instruments for measuring symptoms of depression, anxiety or distress were 
originally developed in psychological studies and are used in the scientific context or for 
diagnostics in clinical psychology.  
The choice of measurement instruments varies with the specific application and depends, 
among others, on the type of hypotheses proposed, the type of data that should be yielded (i.e. 
qualitative or quantitative), specific characteristics of the sample (i.e. age, ability to read, 
educational level, ability to concentrate) and the amount of available resources (i.e. funding, 
human resources). Researchers need to balance interests and may even make a cost-quality 
trade-off: A structured interview, for example, may yield the preferred type of data and 
reduced the rate of missing data but is more costly than a self-administered questionnaire [29] 
due to additional personnel expenses for the interview, for the data preparation (i.e. 
transcription) and for the data analysis.[30] Depending on the reason for the measurement, the 
choice of instrument may also vary. A quick assessment may call for a short interview or a 
screening questionnaire. In contrast, the monitoring of progress over a long period of time 
requires standardisation to be unaffected by high turnover of staff which is best achieved with 
standardised questionnaires.[31] 
Different types of measurement instruments can be used to measure the effect caregiving has 
on caregivers. However, these instruments may not measure outcomes adequately if they were 
originally developed for a different aim or target group. Measurement errors might occur if 
for example the participants’ understanding of the items differs from the original target group. 
To avoid such measurement errors, it is necessary to validate instruments for the designated 
group of users. Caregivers of dementia patients started getting scientific attention in the 1970s 
[32, 33] and consequently, the first measurement instruments specifically for caregivers were 
developed for the dementia setting. Research in the field of palliative caregivers is a relatively 
recent development and hence validation studies are still needed. 
The situation of palliative caregivers differs from that of dementia caregivers [34]: In 2017, 
80,4% of patients treated in palliative care facilities in Germany patients had cancer.[35] The 





usually diagnosed at an older age.[36] Cancer diagnoses can hit people of all ages, even 
though the prevalence increases with age.[37] The specific symptoms that patients show 
result in different care situations and the diseases show diverse timelines regarding onset and 
diagnosis. Caregivers and patients are often caught off guard by a cancer diagnosis and can 
instantaneously be confronted with existential questions due to the rapid development of some 
types of cancer. This surely contributes to end-of-life caregivers being one of the most highly 
burdened groups of caregivers [38], if not the most burdened [7]. 
One of the first measurement instruments designed for caregivers is the Zarit Burden 
Interview (ZBI).[39] The Zarit Burden Interview (ZBI) was developed in English for carers of 
patients with dementia. The ZBI consists of 22 items covering physical, psychosocial and 
financial burden of caregivers and was developed as a structured interview conducted by the 
researcher.[40, 41] While the name “interview” was kept, the interview style was replaced by 
the more economical paper-and-pencil questionnaire. As answering 22 items can be time 
consuming, shorter versions of the ZBI for caregiver burden were established using only 
certain items of the 22-item version.[42, 43] There was no adequate and validated shorter 
version of the ZBI for carers of palliative care patients. Therefore, Higginson et al. compared 
short version of the ZBI and developed the seven-item version ZBI-7 version for the palliative 
care setting.[44] Their ZBI-7 showed very good validity, internal consistency and 
discriminatory performance and the ultra-short, one-item ZBI-1 showed suitability for 
screening purposes.[44] 
In 2010, the ZBI-22 was translated into German and validated in a study addressed at female 
caregivers of patients with dementia [45] but no German version of the ZBI had been 
validated for the palliative care context. The validity of a measurement instrument is its 
capability to measure what it claims to measure and is regarded as one of the most important 
qualities of a measurement instrument.[46] The first study included in this thesis is a 
validation study with the aim of validating the ZBI-7 in the palliative context.[47]  
1.3 Interventions for palliative caregivers  
Informal caregivers’ role in providing vital care for end-of-life patients has gained 
appreciation since the 1980s.[48] Research shows that health care for the patient can have 
positive effects on caregivers. Hospice care for patients, for example, is suggested to mitigate 
the increased mortality of the caregivers after becoming widowed.[49] While this approach is 
respectable, a direct impact on caregivers’ well-being should be more effective. Hence, there 





gradually not only perceived as providers of care but also as “users of services” which 
recognises that caregivers have health and social needs themselves.[54] Due to this dual 
position, ensuring appropriate support for caregivers presents challenges.[51] Obstacles in the 
access of interventions might lie in caregivers’ ambivalence regarding their own needs, as a 
qualitative study suggests [27]: Informal caregivers often do not identify as caregivers 
because they see their caregiving role as a part of the relationship with the patient. To some 
caregivers it seems abnormal to have a professional nurse take over caregiving, which 
prevents them from making use of professional help. Many caregivers feel more comfortable 
contacting nursing staff on behalf of the patient than for themselves and postpone their needs 
to a point after caregiving, aware that they will “fall apart”.[27] Taking part in an intervention 
programme usually means to spend time away from the patient, which can be ambivalent to 
some caregivers who report being torn between the desire for time away from the duty of care 
and an unwillingness to leave the patient.[27] 
Different types of interventions have been developed and meta-analyses or reviews on 
caregiver interventions have defined different categories of interventions.[55-57] So-called 
respite services take over care for the patient which should result in a period of rest for the 
caregiver.[55, 58] However, these programmes can lead to adverse effects if the caregiver 
performs other tasks instead of relaxing or if the substitute care is not adequate.[55, 58] Given 
the fact that for some caregivers leaving the patient is a serious obstacle to participation, there 
are also interventions designed for patient/caregiver dyads.[59, 60] Low-threshold support for 
caregivers can be provided in form of psychoeducational talks or presentations.[56, 57] A 
more intense option is therapeutic counselling, which is usually conducted in an individual 
setting similarly to a therapy session.[56] Skills-based interventions, in contrast,  are typically 
offered in a group-setting. Although they often focus on improving physical care provided by 
caregivers, a number of programmes also include self-care skills.[57] 
While the need for effective caregiver support is recognised and different kinds of supportive 
programmes have been developed [55-59], the range of models remains narrow in relation to 
caregivers’ needs and preferences [59]. It has been criticised that many interventions have had 
a ‘repair’ approach and that more emphasis should be on proactive approaches to prevent 
adverse effects in the first place.[51] 
Mindfulness-based interventions (MBIs) could close this gap as they offer an empowering, 
participatory approach to help caregivers cope better.[53] MBIs are often delivered in a group 





trying to change it.[61] Mindfulness, along with acceptance and questions of meaning and 
values, has been part of the “third wave” of cognitive behavioural therapy (CBT) declared in 
2004.[62, 63] Since studies have found that MBIs can contribute to coping better with stress 
brought upon by daily life as well health problems [64, 65], mindfulness could also be well 
applicable to informal caregivers. Increased self-efficacy involves perceiving oneself as more 
capable to cope with a certain situation [53] which, based on Seligman’s theory [22], should 
reduce the belief of being helpless and could consequently prevent negative effects of 
caregiving.   
The third wave of CBT and its impact on psychotherapy inspired Fegg and colleagues to 
develop a new intervention programme for caregivers of palliative patients.[66] Due to 
caregivers’ confrontation with death, they included not only third wave elements but also 
approaches of existential therapy [67] and therefore called the intervention Existential 
Behavioural Therapy (EBT).[66] EBT is a manualised group intervention aimed at caregivers 
of in-patients on a palliative ward. It provides a space for the exchange on existential 
questions of death and bereavement, in combination with mindfulness practice, stress 
management, self-care and the finding of meaning. The programme consists of six sessions 
with a total of 22 hours. EBT was tested in a randomised controlled trial (RCT) and compared 
with a control group receiving the usual support offered at the institution (e.g. specialist 
palliative care physicians and nurses, chaplains, social workers, psychologists and 
bereavement group). Compared to the control group, the authors found medium to large 
effects on anxiety and quality of life and medium effects on depression.[66] As the inclusion 
rate for the intervention was only 13.6%, the authors suspected the reason to be a self-
selection process resulting in only caregivers in need participating.[66] It is also possible that 
the number of appointments, the group setting or the waiting time until the start of the 
intervention could have discouraged caregivers to participate.  
In view of these considerations, EBT was shortened and adjusted to an individual setting to 
make the intervention more compatible with caregivers’ daily life. The EBT short version 
(sEBT) incorporated the components that participating caregivers had reported most useful in 
an accompanying qualitative study: strengthening resources and mindfulness practice. The 
resulting sEBT consisted of two one-hour sessions in a one-on-one setting with a 
psychologist. The second study included in this thesis is a randomised controlled trial testing 






1.4 Contribution to publications 
Contribution to publication I 
As first author of this study, I wrote the publication to this study, which was then read, 
commented on and approved by all co-authors. Farina Hodiamont had initially obtained 
funding and had concepted the study together with Claudia Bausewein, additional advice was 
provided by Martin Fegg. My responsibilities were the recruitment of informal caregivers in 
three settings: the two inpatient settings of palliative ward and palliative support team and in 
the outpatient setting of the palliative home care team; communication with the latter was 
supported by Farina Hodiamont. Further, I was in charge of communicating with the 
participants, handing out or posting questionnaires as well as entering paper-pencil data into 
the statistical database. On my initiative, the original wording of the questionnaire was 
challenged, the new wording discussed and finally approved by all authors. I conducted the 
statistical data analyses which included the descriptive statistics and the validation analyses 
such as the confirmatory factor analysis and its prerequisite conditions. Christina 
Ramsenthaler provided statistical advice and conducted the Rasch analysis.  
Contribution to publication II 
As first author of this study, I wrote the publication to this study, which was then read, 
commented on and approved by all co-authors. A main part of my work was the 
implementation of the study designed by Martin Fegg. With my appointment, the study was 
re-launched after it had been suspended for five months. Between July 2016 and February 
2018, I contacted informal caregivers on the palliative ward and recruited two thirds of the 
participants. Claudia Bausewein provided advice for recruitment. While the interventions 
were conducted by Sarah Siebert, it was my responsibility to randomise participants, make 
appointments, assign and post the correct questionnaires at the designated time, to ensure the 
return of questionnaires and to enter paper-pencil data into the statistics database. Linda 
Marchioro and Veronika Deffner provided statistical advice and designed the general linear 
mixed regression model. I implemented this model for the specific outcome measures and 
conducted all other statistical data analyses, including the descriptive statistics, the binary 
logistic regression model for the decliners’ follow-up and the analysis of direct health care 






This thesis includes two studies on informal palliative caregivers with the first study 
concerning the measurement of caregiver burden [47] and the second study introducing a 
short-term intervention for caregivers [68]. In this thesis, the term ‘informal caregivers’ 
covers all persons whose care for the patient is not financially rewarded, such as family 
members, friends or neighbours.[6]  
The first study is a validation study for two short versions of the outcome measure Zarit 
Burden Interview (ZBI), which measures caregiver burden and originally comprises 22 
items.[39, 47] The ZBI and the short-version ZBI-7 are valid instruments for measuring 
caregiver burden in advanced cancer and dementia [44] but there has not yet been a validation 
for a wider palliative care setting with non-cancer diseases. Therefore, in this prospective, 
cross-sectional study, the two ZBI short versions ZBI-1 and ZBI-7 were validated for 
informal caregivers in inpatient and outpatient palliative care settings.[47] The methods of 
this validation study included the analysis of response distribution and missing items to test 
content validity and acceptability; confirmatory factor analysis and Rasch analysis to assess 
the structural validity of the ZBI-7; internal consistency and inter-rater reliability were used to 
assess reliability; and known-groups comparisons as well as a-priori hypotheses on 
correlations with Brief Symptom Inventory [69], Short Form-12 [70], Distress Thermometer 
[71] were used to test construct validity.[47] The results showed, that the structural validity 
assessment confirmed the unidimensional structure of ZBI-7, that the item on overall burden 
was the best item for the ultra-short version ZBI-1 and that higher burden was recorded for 
women and for participants with poorer physical health.[47]  While internal consistency was 
good, inter-rater reliability was moderate as proxy ratings estimated caregivers’ burden higher 
than caregivers’ self-ratings.[47] In conclusion, ZBI-7 is a valid instrument for measuring 
caregiver burden in palliative care and the ultra-short ZBI-1 can be used as a quick and proxy 
assessment when considering higher staff ratings.[47]  
The second study is a randomised controlled trial (RCT) testing the effectiveness of short-
term Existential Behavioural Therapy (sEBT) in comparison to an active control group.[68] 
Since informal palliative caregivers have an increased risk for psychological morbidity 
compared with the general population [16], sEBT aims at lowering psychological symptoms 
using mindfulness practice and resource activation.[68] sEBT is based on the group 
intervention EBT which originally comprised 26 hours.[66] The short-term version sEBT 
comprises only two one-hour sessions which are conducted by psychologists in an individual 





Shortening the intervention aimed at increasing inclusion rate compared to the original 
EBT.[66, 68] The primary outcome of this study was depression; secondary outcomes were 
anxiety, subjective distress and minor mental disorders, positive and negative affect, 
satisfaction with life, quality of life and direct health care costs.[68] There were four times of 
investigation, before (pre) and after the intervention (post) as well as four weeks and three 
months after the intervention. General linear mixed models were used which allow various 
measurements for each participant and take change over time into account.[68] The main 
analysis was based on data of 127 participants and the results showed that the level of post-
treatment depression and the secondary outcomes were not significantly associated with 
participation in either sEBT or the control intervention, instead most of the outcomes were 
significantly associated with the time of the investigation and the individual pre-intervention 
level.[68] 54 caregivers who had declined the intervention were included in a follow-up of 
decliners which showed that the following factors contributed significantly to the decision to 
decline: self-efficacy, scepticism of the benefit of the intervention, belief of better coping 
alone and support by family and friends.[68] In conclusion, by shortening the intervention, 
inclusion rate was traded for effectiveness and the intervention could not impact caregivers’ 
psychological state.[68] It is suggested, that sEBT should be included in early integration of 
palliative care, that individual and group setting could be combined and that an optimal length 
for caregiver interventions should be investigated since the intervention used in this study was 







Diese Arbeit enthält zwei wissenschaftliche Studien, in deren Mittelpunkt Angehörige von 
Palliativpatienten (informal caregivers) stehen. Während die erste Studie die Messung der 
Belastung Angehöriger behandelt [47], ist die zweite Studie einer Kurzzeit-Intervention für 
Angehörige gewidmet [68]. Unter Angehörigen von Palliativpatienten werden in dieser Arbeit 
alle Personen verstanden, deren Betreuung, Unterstützung oder Pflege des Patienten nicht 
finanziell entschädigt wird, wie z.B. Familienmitglieder, Freunde oder Nachbarn.[6]  
Die erste Studie ist eine Validierungsstudie für zwei Kurzversionen des Messinstruments 
Zarit Burden Interview (ZBI), welches die Belastung (burden) von Angehörigen misst und in 
der ursprünglichen Fassung 22 Items umfasst.[39, 47] Das ZBI und die Kurzversion ZBI-7 
sind valide Instrumente, um Belastung bei Angehörigen von Patienten mit fortgeschrittenen 
Krebserkrankungen oder Demenz zu messen.[44] Bisher wurde das Instrument jedoch noch 
nicht im palliativen Setting und für Angehörige von Patienten mit einem breiten Spektrum an 
Erkrankungen validiert. Daher wurden in der vorliegenden prospektiven Querschnittstudie die 
ZBI-Kurzversionen ZBI-1 und ZBI-7 mit einer Stichprobe von Angehörigen aus dem 
stationären und dem ambulanten palliativen Setting validiert.[47] Die Methoden der Studie 
umfassten die Analyse von Antwortverteilung und fehlenden Werten, um Inhaltsvalidität und 
Akzeptanz des ZBI-7 zu testen; anhand der konfirmatorischer Faktorenanalyse und der 
Rasch-Analyse wurde die strukturelle Validität getestet; interne Konsistenz und die Interrater-
Reliabilität wurden als Maße der Reliabilität verwendet; und es wurden Vergleiche mit 
bekannten Gruppen (known-group comparisons) angestellt sowie A-priori-Hypothesen zu 
Korrelationen mit den Messinstrumenten Brief Symptom Inventory [69], Short-Form-12 [70] 
und Distress Thermometer [71] geprüft, um die Konstruktvalidität des ZBI-7 zu testen.[47] 
Die Ergebnisse zeigten, dass die Analyse der Strukturvalidität die unidimensionale Struktur 
des ZBI-7 bestätigte, dass das Item zur Gesamtbelastung sich als bestes Item für die Ultra-
Kurzversion ZBI-1 erwies und dass eine höhere Belastung bei Frauen und bei Teilnehmern 
mit schlechterem physischen Gesundheitszustand gemessen worden war.[47] Während die 
interne Konsistenz gut war, ergaben sich für die Inter-Rater-Reliabilität mittlere 
Übereinstimmungen, da die Fremdeinschätzung der Belastung höher war als die 
Selbsteinschätzung durch die Angehörigen.[47] Zusammenfassend zeigte sich, dass der ZBI-7 
ein valides Instrument ist, um die Belastung Angehöriger im palliativen Kontext zu messen 
und, dass das ultra-kurze ZBI-1 für eine kurze Einschätzung und als Fremdeinschätzung 
verwendet werden kann, wenn eine mögliche Überschätzung der Belastung durch die 





Die zweite Studie ist eine randomisiert-kontrollierte Studie (RCT), in der die Kurzzeit-
Intervention Short-term Existential Behavioural Therapy (sEBT) auf ihre Wirksamkeit im 
Vergleich mit einer aktiven Kontroll-Intervention getestet wurde.[68] Da das Risiko für 
psychische Erkrankungen bei Angehörigen von Palliativpatienten im Vergleich zur 
Normalbevölkerung deutlich erhöht ist [16], soll sEBT, durch die Vermittlung von 
Achtsamkeit und die Aktivierung von Ressourcen, psychische Symptome von Angehörigen 
mindern.[68] sEBT basiert auf der Gruppen-Intervention EBT, die ursprünglich insgesamt 26 
Stunden umfasste.[66] Die Kurzzeit-Version sEBT umfasst nur zwei einstündige Sitzungen, 
die im Einzelsetting von Psychologinnen durchgeführt werden, und soll daher 
alltagskompatibler für Angehörige sein.[68] Durch die Kürzung der Intervention sollte eine 
höhere Teilnehmerquote erreicht werden als bei der Vorgänger-Version EBT.[66, 68] Das 
primäre Outcome der vorliegenden Studie war Depression, sekundäre Outcomes waren Angst, 
subjektiver Distress, geringfügige psychische Störungen, positiver und negativer Affekt, 
Lebenszufriedenheit, Lebensqualität und direkte Gesundheitskosten.[68] Die Messzeitpunkte 
der Studie lagen vor (prä) und nach der Intervention (post) sowie im Abstand von vier 
Wochen und drei Monaten nach der Intervention. Es wurden allgemeine lineare Modelle 
verwendet, um mehrere Messungen pro Teilnehmer zuzulassen und Veränderungen über die 
Zeit hinweg sichtbar zu machen.[68] In die Hauptanalyse wurden die Daten von 127 
Teilnehmern einbezogen und die Ergebnisse zeigten, dass es keinen signifikanten 
Zusammenhang zwischen den Werten von Depression zum Post-Messzeitpunkt und der 
Teilnahme an sEBT oder der aktiven Kontrollgruppe gab, stattdessen zeigten die meisten 
Outcomes einen signifikanten Zusammenhang mit dem Messzeitpunkt sowie dem 
individuellen Ausgangswert vor Beginn der Intervention.[68] 54 Angehörige, die die 
Teilnahme an der Intervention abgelehnt hatten, wurden in eine zusätzliche Befragung 
eingeschlossen, welche ergab, dass die folgenden Faktoren eine signifikante Rolle bei der 
Ablehnung der Intervention spielten: Selbstwirksamkeitserwartung, Skepsis gegenüber dem 
Nutzen der Intervention, die Überzeugung, besser allein zurecht zu kommen und 
Unterstützung von Familien und Freunden.[68] Zusammenfassend zeigte sich, dass durch die 
Kürzung der Intervention zwar eine höhere Einschlussquote erreicht wurde, dafür aber die 
Effektivität der Intervention beeinträchtigt wurde und sie den psychischen Zustand der 
Angehörigen nicht beeinflussen konnte.[68] Es wird angeregt, sEBT in die frühe palliative 
Versorgung (early integration) einzubinden, das Einzel-Setting mit dem Gruppen-Setting zu 
verknüpfen sowie weiter an der optimalen Länge für Angehörigen-Interventionen zu forschen, 
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Abstract
Purpose Several validated outcome measures, among them the Zarit Burden Interview (ZBI), are valid for measuring
caregiver burden in advanced cancer and dementia. However, they have not been validated for a wider palliative care
(PC) setting with non-cancer disease. The purpose was to validate ZBI-1 (ultra-short version and proxy rating) and ZBI-7
short versions for PC.
Methods In a prospective, cross-sectional study with informal caregivers of patients in inpatient (PC unit, hospital palliative
support team) and outpatient (home care team) PC settings of a large university hospital, content validity and acceptability of the
ZBI and its structural validity (via confirmatory factor analysis (CFA) and Rasch analysis) were tested. Reliability assessment
used internal consistency and inter-rater reliability and construct validity used known-group comparisons and a priori hypotheses
on correlations with Brief Symptom Inventory, Short Form-12, and Distress Thermometer.
Results Eighty-four participants (63.1% women; mean age 59.8, SD 14.4) were included. Structural validity assessment con-
firmed the unidimensional structure of ZBI-7 both in CFA and Rasch analysis. The item on overall burden was the best item for
the ultra-short version ZBI-1. Higher burden was recorded for women and those with poorer physical health. Internal consistency
was good (Cronbach’s α = 0.83). Inter-rater reliability was moderate as proxy ratings estimated caregivers’ burden higher than
self-ratings (average measures ICC = 0.51; CI = 0.23–.69; p = 0.001).
Conclusion The ZBI-7 is a valid instrument for measuring caregiver burden in PC. The ultra-short ZBI-1 can be used as a quick
and proxy assessment, with the caveat of overestimating burden.
Keywords Caregivers . Caregiver burden . Palliative care . Validation studies . Zarit burden interview . Psychometrics
Introduction
According to the WHO definition, palliative care (PC) ad-
dresses the needs of patients and offers a support system to
help the family cope during the patients’ illness and in be-
reavement [1]. Not only family members but also friends or
neighbours can be involved in taking care of a patient, and as
long as their support is not financially rewarded, they can be
defined as informal caregivers [2].
Informal caregivers can become “patients” themselves, as
their psychological morbidity is substantially higher com-
pared with the general population [3]. There is a close rela-
tionship between the patient’s perceived burden and that of the
caregiver [4, 5], often leading to higher caregiver burden in the
later stages of the patient’s illness and a corresponding
increase in need for physical and emotional support for
caregivers [6, 7].
There is a growing number of intervention programmes [8,
9] aiming at caregiver outcomes, such as reducing caregivers’
burden, improving caregivers’ coping, or their quality of life.
However, quantifying the impact of interventions is impossi-
ble without validated outcome measures for caregivers. A sys-
tematic review by Michels et al. showed that the majority of
studies measuring informal caregiver outcomes in PC use
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carer-specific measures, primarily measures of caregiver bur-
den [10]. According to Michels et al. the Zarit Burden
Interview (ZBI) [11] is one of the two most frequently used
measures of burden [10], the other one being the caregiver
reaction assessment (CRA) [12]. The ZBI, originally compris-
ing 22 items [11, 13, 14], has several short forms including
between four and twelve items, and the overall burden is
assessed by the total score of all items, with a higher score
representing greater caregiver burden [15–17]. Higginson
et al. validated ZBI short versions in advanced conditions with
caregivers of patients with advanced cancer, dementia, and
acquired brain injury (ABI) [18]. The authors recommended
using ZBI-6 and ZBI-7 (ZBI-6 plus ZBI-1) in the PC setting as
they showed good validity, internal consistency, and discrim-
inatory performance. Additionally, it was reported that the
ZBI-1 might be suitable for screening [18].
However, although the ZBI is well-known and used, a for-
mal validation of ZBI short versions in the PC setting using
psychometric testing and Rasch analysis, and complementing
the results Higginson et al. [18], is still lacking. Furthermore,
the German ZBI 22-item version was validated by Braun et al.
[19] for female caregivers of dementia patients, but not vali-
dated in a German PC setting yet.
The palliative care context differs from dementia due to
often rapidly progressing diseases, and caregiving at the end
of life causes the greatest caregiver burden. [20]
Therefore, the aim of this study was (1) to test the ZBI-7,
the ZBI-6, and the ZBI-1 short versions for content validity,
structural validity, construct validity, and reliability in the PC
setting; (2) to confirm findings using Rasch analysis; (3) to
evaluate the suitability of ZBI-1 as a proxy assessment for
staff members; and (4) to evaluate the suitability of ZBI-1 item
as an ultra-short instrument for quick assessment based on
validity, reliability, and Rasch analysis.
Methods
Design
This is a prospective, cross-sectional validation study.
Psychometric properties are reported according to the
Consensus-based Standards for the selection of health status
Measurement Instruments (COSMIN) guidelines [21, 22] and
the quality criteria for measurement properties of health status
questionnaires by Terwee et al. [23]. The Ethics Committee of
the Ludwig-Maximilians University Munich approved the
study (REC-No 772–16).
Setting and population
The study was conducted in the Department for Palliative
Medicine at Munich University Hospital. Informal caregivers
of patients treated by the hospital support team, and the home
care team were consecutively recruited.
In the inpatient PC unit, questionnaires were included in
the pre-intervention assessment of a randomized controlled
trial evaluating an intervention for informal caregivers
(Clinical.Trials.gov registration NCT02325167). The
combination of the two studies was approved by the
university’s ethics committee.
Inclusion criteria were being an informal caregiver of
a palliative patient, a minimum age of 18 years, profi-
ciency in written and spoken German, and the ability to
give written informed consent. Caregivers with poor
general condition, caregivers of patients who had been
admitted to PC the same day, or who were imminently
dying were excluded. Eligibility for inclusion was
assessed by a staff member.
All participating caregivers and patients provided written
informed consent. Consent of a legal guardian was sought for
those patients unable to give consent.
Data collection
Data were collected between February 2017 and
February 2018 using self-assessed questionnaires.
Demographic data included age, sex, ethnicity, religion,
highest academic qualification, profession, and marital
status. Information on type of relation to the patient,
role in caring for the patient, and the living status was
collected for caregivers. Patient data were collected
from medical notes and included age, date of PC admis-
sion, symptom burden at day of admission (via routine-
ly collected Integrated PC Outcome Scale [24]), diagno-
sis, and date of discharge or death.
A member of the attending PC team assessed caregiver
burden as a proxy using the ZBI-1 for inter-rater agreement.
Staff members were asked for written informed consent and
the following demographic data: age, sex, profession, work
setting, and years of experience in PC.
Caregivers, who appeared highly burdened personally or in
the assessments, were offered additional supportive talks by
the multidisciplinary team.
Measurement instruments
Zarit Burden Interview-7 (ZBI-7): 7-item version of the orig-
inal 22-item version measuring caregivers’ physical and psy-
chosocial burden on a five-point Likert scale [13, 18]. From
the German translation by Braun et al. [19], we chose the
seven items (see Table 1) recommended for use in PC by
Higginson et al. [18]
Brief Symptom Inventory (BSI): measuring psychological






Distress thermometer: one-item measure with a 0–10 scale
ranging from “No distress” to “Extreme distress” [26].
Short form 12:12-item version of the Short Form Health
Survey measuring subjective health status on three- and five-
point Likert scales [27].
Analysis
Descriptive statistics were used to describe sample
distribution and distribution of responses. Missing data
were imputed using expectation-maximization technique
as data was missing completely at random, as indicated
by the non-significant chi2 statistic in Little’s MCAR test
performed in SPSS [28].
Sample size
Two sample size calculations were conducted to power the
study for detecting moderate reliability scores and to allow
the detection of medium differences between known
subgroups regarding the extent of burden (d = 0.3 at a
power of 80% and at a significance level of 95%).
Sample size estimates ranged from 64 to 144 participants,
with a minimum of 90 participants needed to detect
known-group differences.
Validity analysis
Content validity and acceptability comprised the analysis of
ceiling and floor effects, indicated if more than 15% of re-
sponses are in the highest or lowest category [23], as well as
assessment of acceptability by analysis of missing items and
user comments.
Structural validity: confirmatory factor analysis (CFA)
were run to confirm that all items load on one latent factor,
excluding the existence of subscales [29]. CFA was run with
maximum likelihood estimation as it is robust to minor devi-
ations from normality and accounts for missing data [30, 31].
Evaluation of model fit was based on fit indices and on the
chi2/df-ratio rather than on chi2, as the latter reacts sensitively
to sample size [32]. A chi2/df-ratio between 2 and 3 was
regarded as indicative of acceptable data-model fit [32, 33].
Fit indices of CFI/TLI ≥ 0.90 were regarded acceptable, and
root mean square error of approximation (RMSEA) < 0.08
was regarded as showing good fit [31].
Construct validity: we tested a priori hypotheses on
scale-to-scale correlations with other measures, assuming
that high correlations imply high convergent validity and
suggest that the two scales measure similar concepts [34].
BSI, Distress Thermometer, and SF-12 were chosen, as
they are well-known and established measurement
instruments and, while not explicitly validated for caregivers
in palliative care, have all been used in studies on this
population [35, 36].
Twelve a priori hypotheses were formulated on ZBI-1,
ZBI6, and ZBI-7—each correlating significantly with the
BSI subscales depression and Global Severity Index, with
the Distress Thermometer and the SF-12 subscale Mental
Health Composite. Moderate correlations (0.4–0.7) were
assumed, as all measures represent different aspects of
burden-related caregiver outcomes. The family-wise alpha
error rate was Bonferroni-corrected to a value of 0.05/
12 = 0.004.
Construct validity was also determined through known-
groups comparisons [34]. Eight hypotheses were formulated.
We hypothesised that burden would be higher for female care-
givers, due to studies suggesting sex differences [37, 38].
Table 1 Short versions, item wording, and distribution of responses (n = 84)
Short versions Responses (%)
ZBI 7 ZBI 6 ZBI 1 Items 0 1 2 3 4 Miss
Y Y 1. Do you feel you do not have enough time for yourself? 17.9 21.4 41.7 14.3 4.8 0
Y Y 2. Do you feel stressed between caring and meeting other responsibilities? 19.0 26.2 28.6 20.2 6.0 0
Y Y 3. Do you feel your relative affects your relationship with others in a negative way? 56.0 21.4 16.7 3.6 1.2 1.2
Y Y 4. Do you feel strained when are around your relative? 34.5 27.4 27.4 9.5 1.2 0
Y Y 5. Do you feel your health has suffered because of your involvement with your relative? 32.1 20.2 35.7 8.3 3.6 0
Y Y 6. Do you feel you have lost control of your life since your relative’s illness? 48.8 17.9 20.2 9.5 2.4 1.2
Y Y 7. Overall, how burdened do you feel in caring for your relative? 6.0 17.9 27.7 44.6 3.6 1.2
Y: yes
Italic: responses > 15%; indicating floor-effects
Miss: percentage of missing items
Possible responses to item 1–6: 0, never; 1, rarely; 2, sometimes; 3, quite frequently; 4, nearly always





Furthermore, a block of hypotheses referred to (a) the relation-
ship between caregivers and patient. It was hypothesised that
burden would be higher for (i) parents or partners as losing a
child conflicts with life cycle expectations, and losing a part-
ner is ranked as one of the most stressful life events [39]; (ii)
those living with the patient as studies suggest that there are
more negative consequences for caregivers when caregiving
in-house [40]; (iii) those giving physical care to the patient,
and (iv) those who had power of attorney or legal guardian-
ship for the patient as we suspected a relationship to burden,
since caregivers are neither trained nurses nor legal guardians.
A second block of hypotheses referred to (b) caregivers
who felt physically strained which can impact on caregivers’
distress [38]. It was hypothesised that ZBI outcomes would be
higher for (i) those who scored high on the SF-12 Physical
Health Composite (via median split); those who due to phys-
ical health in the past 4 weeks (SF-12) (ii) had accomplished
less or (iii) had been limited in work or activities. Parametric
tests were used for all comparisons, complemented by non-
parametric tests to account for non-normal distribution (t-test
and Kruskal-Wallis H-test for hypothesis (a, i); t-test and
Mann-Whitney-U tests for all other hypotheses). Hypotheses
were tested using non-imputed data to avoid misleading re-
sults due to imputation.
The first block of known-group comparisons was tested to
a Bonferroni-corrected alpha of 0.05/8 = 0.006; and the last
block to a corrected alpha of 0.05/3 = 0.017.
Reliability analysis
Internal consistency was assessed as an aspect of reliability
[41]. Cronbach’s α = 0.7–0.9 indicated internal consistency
without item redundancy.
Inter-rater reliability between self-rating of burden and
proxy rating by a staff member was examined with the
Intraclass Correlation Coefficients (ICC) [21] and a two-way
mixed model of the type consistency [42]. ICC < 0.5 indicated
poor reliability, ICC of 0.5–0.75 moderate, 0.75–0.90 good,
and ICC > 0.90 excellent reliability [42].
Rasch analysis
Rasch analysis complemented the validity analyses and tested
items for use as an ultra-short version. The Rasch measurement
model tests validity of unidimensional measures. It assumes
that the response to a ZBI item is determined by the level of
burden a person experiences (person fit) and the level of burden
that the item represents (item fit). The Partial Credit Model was
used which does not require equidistant categories and is suit-
able for ordinal-level data. ZBI-7 and ZBI-6 were compared
with each other, and for ZBI-1 the self-rating data was com-
pared with the one-item proxy rating by staff members.
Best-performing item candidates for the ultra-short
version ZBI-1 were determined by item fit residuals
(<and> 2.5), a summary mean item and person fit close
to 0 (with SD = 1), ordered Likert response scale
weightings for individual answer categories for each
item, and the overall floor and ceiling effect for item
parameters to person parameters. Overall model fit was
assessed using the X2-test [43, 44].
CFAwas run using IBM SPSS Amos 25 [45]. Rasch anal-
ysis was conducted using RUMM 2030 [46]. For all other
analyses, SPSS version 25 was used [47]. A p value of <
0.05 was considered significant.
Results
Acceptability
Overall, 123 informal caregivers participated. Acceptability
was assessed after 39 participants had completed the question-
naires. In open-response text fields, problems with the
German translation of “care” were noted. Two participants
commented “I don’t nurse” and “No nursing” and 2.6–7.7%
of items were missing. We therefore decided to change the
wording of the German translation and employed the revised
version on a sample of 84 participants. Percentage of missing
items dropped to 0–1.2%, and overall, the revised version
showed better characteristics than the first version. All follow-
ing analyses in this study were conducted with data of the
revised German version only (n = 84).
Characteristics of participants
Data of 84 participants who received the revised ZBI-7 were
included in the analyses. Figure 1 shows the participant flow
of the three settings. Most participants were female (63.1%;
see Table 2); the mean age was 59.8 years (standard deviation
(SD) 14.4). Approximately, one third of the participants held a
university degree (32.1%), and the majority were married
(76.2%). Participants were mostly partners (including wives
or husbands) (53.6%) or children (32.1%) of the patients.
Cancer was the prevailing diagnosis of the patients (79.8%).
For characteristics of participating staff members
see electronic supplementary material 1.
Structural validity
Scores were non-normally distributed for items 3, 6, and 7,
with skewness of 1.215 (standard error (SE) = 0.264), 0.842
(SE = 0.264), and − 0.582 (SE = 0.264), respectively; the
latter left-skewed, all others right-skewed. Floor effects were






The CFA analyses showed a good to moderate fit of a
unidimensional model, meaning that all items in the ZBI short
versions measure one construct, caregiver burden, only. Fit
indices were good (CFI = 0.938, TLI = 0.907, standardized
RMR = 0 . 0 6 4 3 ) , a n d RMSEA w a s m o d e r a t e
(RMSEA = 0.100, 90% confidence interval (CI) = 0.033–
0.161). The chi2/df-ratio was 1.84, also indicating a good fit
to a unidimensional model. Overall, the fit indices and other
measures (absence of Heywood cases, meaning negative var-
iances or implausible values for variances and factor loadings)
of fit confirm a unidimensional model of caregiver burden and
the potential to shorten the ZBI further. All factor loadings
were above 0.30, indicating good yet variable ability of indi-
vidual items in the ZBI to measure the underlying construct of
caregiver burden. Factor loadings varied between 0.41 for
item 3 and 0.81 for item 7 on overall burden. Item 7 loaded
highest onto the latent variable “burden” and showed the
highest level of explained variance (see Table 3). ZBI-6
showed lower factor loadings and explained variance, as it
lacks the overall item 7. The following results are therefore
reported for ZBI-1 and ZBI-7 only.
Convergent validity
Correlations between the ZBI-1 and ZBI-7 scales and individ-
ual Zarit items with the Distress Thermometer, the SF-12
Mental Health subscale, the BSI global scale, and BSI depres-
sion subscale were analysed. Of the 12 a priori hypotheses
nine, 75%, had hypothesised the correct direction of correla-
tions (Bonferroni-corrected alpha level of 0.004; see Table 4).
Known-group comparisons
Caregiver burden measured with ZBI-7 was significantly
higher for female caregivers The results for the outcome
ZBI-1 did not reach statistical significance, based on the
Bonferroni-corrected alpha level of 0.006 (ZBI-1 t = 2.32,
p = 0.023; ZBI-7 t = 2.96, p = 0.004). No hypothesis in block
(a) regarding relationship between carers and patient was
significant.
In block (b), one of the three hypotheses concerning care-
givers who felt physically strained was significant (b ii):
Caregiver burden was significantly higher measured with
ZBI-7 for those who had indicated on SF-12 that they had
accomplished less in the past 4 weeks due to their physical
health. The results for the outcome ZBI-1 did not reach statis-
tical significance, based on the Bonferroni-corrected alpha
level of 0.0017 (ZBI-1 t = 2.01, p = 0.048; ZBI-7 t = 3.32,
p = 0.001). Comparisons were also run using non-parametric
tests, yielding the same pattern of significant and non-
significant results.
Reliability
Cronbach’s α for the ZBI-7 scale was 0.83 and was reduced
with removal of any item. Item 7 on overall burden (ZBI-1)
correlated highest with the whole ZBI-7 scale (r = 0.73) and if
deleted reduced Cronbach’s α most (ZBI-6, Cronbach’s α =
0.78).
ICC was significant for the 1-item ratings by staff members
and informal caregivers. Agreement, however, was moderate
for average measures (ICC = 0.51; CI = 0.23–.69; p = 0.001).
ICCs for the 1-item ratings of staff members and caregivers’
ZBI-7 self-rating were not significant (p = 0.211; single mea-
sures, ICC = 0.09; CI = − 0.13–0.31; average measures
ICC = 0.17; CI = − 0.31–0.47).
Rasch analysis
All three models (ZBI-7, ZBI-6, and ZBI-1) showed good
model fit. Mean of ZBI-7 item difficulty was 0.00 (SD =
0.63). Item 3 “affecting relationships” measured the highest





levels of burden, while item 7 “overall burden” measured the
lowest levels. There was no major deviation from the Rasch
model as no item showed residuals of ± 2.5 and all chi2 mea-
sures were non-significant (Bonferroni-corrected, p < 0.001,
see electronic supplementary material 2).
The person-item threshold distribution showed a slight
mismatch of item and person parameters (see electronic
supplementary material 3). Items measured the medium to
higher levels of burden. Person parameters (amount of burden
as reported by caregivers), however, showed lower to medium
values. For ZBI-1, the distribution of scores indicated lower
person parameters for caregivers, indicating lower burden,
than was observed for staff members’ proxy ratings. Item
characteristic curves showed that items 5 “health suffered”
and 7 “overall burden” marginally over-discriminated by dif-
ferentiating well between caregivers with high or low burden.
Interval-scale assumption via category probability curves
yielded items 2 “meeting responsibilities,” and 4 “feeling
strained” as most evenly distributed items. Moreover, item 7
“overall burden,” the designated item of the ZBI-1 ultra-short
version, showed comparatively good fit to the Rasch model.
The fit of the self-rated caregiver version (location = 1.172,
SE = 0.136, fit residual = − 0.006) was better than the fit of the
staff version (location = − 1.172, SE = 0.153, fit residual =
0.715).
Discussion
Our aim for this study was to close the gap of a formal vali-
dation of the ZBI short versions in the PC setting.
Additionally, the acceptability of the German ZBI was im-
proved by the change of wording (report in preparation).
Concerning convergent validity, scale-to-scale correlations
were significant but moderate, as expected, due to the compar-
ison instruments measuring different aspects of burden-related
Table 2 Descriptive characteristics of participants (n = 84)
Characteristic n Percentage
Setting
Palliative care unit 47 56.0%
Hospital support team 19 22.6%













University degree 27 32.1%
Upper secondary 12 14.3%
Intermediate secondary 30 35.7%

















Procuration or legal guardianship 72 85.7%
No procuration or guardianship 12 14.3%
Diagnosis of patient
Digestive tract cancer 17 20.2%
Genito-urinary cancer 12 14.3%
Brain cancer 8 9.5%
Lung cancer 7 8.3%
Gynaecological cancer 4 4.8%
Breast cancer 3 3.6%
Hemic cancer 3 3.6%
Other cancer 13 15.5%
Neurological disease 8 9.5%
Cardiovascular disease 2 2.4%
Other disease 7 8.3%
a Mean
b SD
Table 3 Factor loadings of confirmatory factor analyses with EM-
imputed data of ZBI-7 and ZBI-6
ZBI-7 ZBI-6
ZBI Item λ SMC λ SMC
1 0.64 0.41 0.66 0.43
2 0.77 0.60 0.79 0.62
3 0.49 0.24 0.51 0.26
4 0.51 0.26 0.48 0.23
5 0.76 0.58 0.75 0.56
6 0.51 0.26 0.50 0.25
7 0.81 0.65 - -
SMC, squared multiple correlation





caregiver outcomes. Two of the eight hypotheses formulated on
known groups were significant. As suggested by other studies
[37, 38], burden was higher for female caregivers, and for those
with poor physical health, which also concurs with other find-
ings [38]. Unlike expected, caregiver burden was not higher for
those who were partners or parents, who lived with the patient,
physically nursed, or acted as legal guardian.
Our results on reliability for ZBI-7 (Cronbach’s α 0.83)
were only minimally higher than in Higginson et al.’s valida-
tion (α 0.82). [18]
Analysis of structural validity using CFA and Rasch anal-
ysis confirmed the unidimensional structure of the ZBI,
allowing for use of the overall score as outcome measure.
ZBI-7 showed advantages over ZBI-6 in factor loadings, ex-
plained variance, and internal consistency as the additional
item 7 on overall burden proved to be the best item and the
best choice as the ultra-short version ZBI-1.
Our results concerning ZBI-1 differ from Higginson et al.’s
validation study where ZBI-1 for cancer caregivers showed
the lowest discriminative ability and the lowest correlation
with the 22-item version. Higginson et al. obtained 91% sen-
sitivity and 53% specificity for ZBI-1, meaning that ZBI-1
oversensitively rated most caregivers as burdened [18]. In
our study, ZBI-1 showed good fit with the Rasch model,
which means that it discriminated very well between high
and low burden and only when used as a proxy rating by staff
members overestimated caregiver burden.
Using ZBI-1 as a proxy rating, staff members rated care-
givers’ level of burden higher than in caregivers’ self-ratings,
resulting in mediocre inter-rater reliability. Social desirability
could have led to lower self-ratings, as caregivers might have
presented themselves as more stable to prevent their ability to
care being questioned. A potential consequence of personnel’s
higher evaluation of burden could be the provision of support
to caregivers who would not have asked for support
themselves.
Rasch analysis and analysis of content validity suggested
that items were constructed to measure higher levels of burden
but caregivers reported lower levels. This may suggest a com-
paratively poor fit between sample and measure, resulting in
false negative ratings of burden. However, participation bias
could explain floor effects as participating caregivers possibly
felt less burdened than those who decided to decline study
participation. Dura and Kiecolt-Glaser reported a similar ac-
count of caregiver participation bias [48]. Additionally, care-
givers included in this study were recruited from three spe-
cialized PC settings, which could have resulted in them being
less burdened than caregivers who receive less professional
support. Similarly, Higginson et al. reported lower levels of
burden for advanced cancer caregivers, who had been recruit-
ed solely from specialized support facilities, while caregivers
of patients with dementia and ABI showed higher levels of
burden and had been recruited from diverse settings [18].
A strength of this study is that it is the first validation study
of ZBI short versions that focusses on the PC setting alone.
Participants were recruited in all three relevant PC settings.
Additionally, this validation study was conducted with
methods based on classical test theory and with Rasch analy-
sis, which comprises aspects of item-response theory.
Reliability of the ZBI-7 was higher than in previous studies
and relative reliability was tested using inter-rater agreement.
While the ZBI is well-known and used, our study closes the
gap of a formal validation in the PC setting.
Limitations include rather low participant numbers in the
home care setting due to low home care team staffing situation
and high workload. Therefore, initially only few caregivers
Table 4 A priori hypotheses and results for construct validity using spearman correlation coefficients of the ZBI with SF-12 and BSI (n = 84)
Hypothesis Scales correlated rho p
Moderatea convergent validity expected:
Between ZBI scales and BSI (sub-)scale ZBI-1 + BSI Global Severity Index 0.41 0.000
ZBI-6 + BSI Global Severity Index 0.53 0.000
ZBI-7 + BSI Global Severity Index 0.53 0.000
ZBI-1 + BSI depression 0.36 0.001
ZBI-6 + BSI depression 0.45 0.000
ZBI-7 + BSI depression 0.45 0.000
Between ZBI scales and the Distress Thermometer ZBI-1 +Distress Thermometer 0.51 0.000
ZBI-6 + Distress Thermometer 0.35 0.001
ZBI-7 + Distress Thermometer 0.39 0.000
Between ZBI scales and SF-12 subscale Mental Health Composite ZBI-1 + SF12 Mental Health Composite − 0.40 0.000
ZBI-6 + SF12 Mental Health Composite − 0.48 0.000
ZBI-7 + SF12 Mental Health Composite − 0.49 0.000
a Expected correlations: rho (0.4)–(0.7)





had been contacted in this setting, and reasons for exclusion
were not recorded consecutively. Inclusion decisions were
hence recorded by a member of the study team.
Additionally, it must be noted that the recruitment of the big-
gest part of caregivers was combined with an intervention
study, to both preserve resources and spare caregivers, but
the approach might have influenced caregivers’ self-ratings.
This study provides good validity for ZBI-1 as a proxy rating
and potential as an ultra-short instrument, but because of lack-
ing resources further analyses, e.g., of sensitivity or specific-
ity, were not possible. Sample size was slightly smaller than
the minimum of 90 participants needed to detect known-group
differences, and subgroup comparison was infeasible due to
unequal proportion of settings. However, results were obtain-
ed by combining methods of classical test theory and Rasch
analysis and can therefore be regarded as robust.
In conclusion, this study complements earlier results of
Higginson et al. [18]. ZBI-1 and ZBI-7 were shown to be valid
in the PC context. ZBI-1 shows promising indication for use
as an ultra-short instrument for caregiver burden while ZBI-7
could be used for more comprehensive measurement of care-
giver burden, for example, when quantifying the impact of
interventions aimed at caregivers in clinical trials and evalua-
tion studies.
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Abstract
Background: Informal caregivers of palliative patients show higher levels of depression and distress compared with the general 
population. Fegg’s (2013) existential behavioural therapy was shortened to two individual 1-h sessions (short-term existential 
behavioural therapy).
Aim: Testing the effectiveness of sEBT on psychological symptoms of informal caregivers in comparison with active control.
Design: Randomised controlled trial.
Setting/participants: Informal caregivers of palliative in-patients.
Methods: The primary outcome was depression; secondary outcomes were anxiety, subjective distress and minor mental disorders, 
positive and negative affect, satisfaction with life, quality of life and direct health care costs. General linear mixed models allow 
several measurements per participant and change over time. Reasons for declining the intervention were investigated by Rosenstock’s 
Health Belief Model.
Results: Overall inclusion rate was 41.0%. Data of 157 caregivers were available (63.1% females; mean age: 54.6 years, standard 
deviation (SD): 14.1); 127 participants were included in the main analysis. Participation in sEBT or active control was not significantly 
associated with post-treatment depression. Outcomes showed prevailingly significant association with time of investigation. Self-
efficacy, scepticism of benefit of the intervention, belief of better coping alone and support by family and friends were significant 
factors in declining participation in the randomised controlled trial.
Conclusion: Inclusion rate was tripled compared with a previously evaluated longer EBT group intervention. By shortening the intervention, 
inclusion rate was traded for effectiveness and the intervention could not impact caregivers’ psychological state. Early integration of sEBT 
and combination of individual and group setting and further study of the optimal length for caregiver interventions are suggested.
Keywords
Family caregiver, palliative care, existential behavioural therapy, randomised controlled trial
What is already known about the topic?
•• Informal caregivers of palliative patients are prone to higher levels of depression compared with the general 
population.
•• Fegg et al. (2013) developed existential behavioural therapy (EBT) for caregivers as a group intervention comprising 22 h.
•• EBT showed medium to large effects on anxiety and quality of life and medium effects on depression, reaching 13.6% of 
all eligible caregivers.
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Introduction
Informal caregivers are family members and other per-
sons whose support of the patient is not financially 
rewarded.1 Supporting informal caregivers is an essential 
part of palliative care, as defined by the World Health 
Organization.2
Informal caregivers are prone to higher levels of 
depression, anxiety, strain and burden than the general 
population,3,4 and the number of interventions to support 
them is growing.4,5 However, a review of caregiver inter-
ventions identified a lack of proactive interventions and 
supposed that caregivers would prefer interventions that 
improve the ability to care.6
Mindfulness-based interventions for caregivers could 
potentially close this gap. Despite the challenges for car-
egivers to access interventions due to scheduling difficul-
ties and them having to leave the patient alone, 
mindfulness showed positive influences on depression, 
strain and quality of life.7
Fegg et al.8 developed existential behavioural therapy 
(EBT), an intervention aimed at informal caregivers of pal-
liative patients. EBT was implemented in a group setting 
with a total of 22 h focusing on mindfulness practice, 
strengthening resources, finding meaning, establishing 
self-care and developing personal values. Medium to large 
effects on anxiety and quality of life and medium effects 
on depression were demonstrated. A weakness of this 
study was the low uptake of the intervention with 13.6%.
Short-term existential behavioural therapy (sEBT) 
aimed to be more compatible with caregivers’ daily life. A 
qualitative study embedded in the Fegg study had identi-
fied two EBT elements regarded as most helpful by car-
egivers: social support in the group and self-regulation via 
strengthening resources and practicing mindfulness.9 
Despite the support provided by the group, an individual 
setting was chosen for sEBT to ensure a quicker start of 
the intervention. To condense EBT for the individual set-
ting, sEBT focused on the two elements of self-regulation, 
shortening it to two 1-h sessions.
A feasibility study indicated that sEBT was feasible and 
accepted by caregivers.10 Although sEBT is not a treatment 
applied for a disorder, the term ‘therapy’ was kept to mark 
the affiliation with EBT.
This study’s aim was to evaluate the effectiveness of 
the sEBT intervention in comparison with a usual, non-
directive psychological intervention using a randomised 
controlled trial study design.
The primary outcome was informal caregivers’ level of 
depression, as the Fegg study had shown long-term 
effects on depression. Secondary outcomes were informal 
caregivers’ levels of anxiety, subjective distress and minor 
mental disorders, positive and negative affect, satisfaction 
with life, quality of life and direct health care costs.
Furthermore, we analysed caregivers’ reasons to 
decline participation in the randomised trial as more 
research in this field had been suggested.7
Method
Design
This randomised controlled trial has a parallel-group 
design with equal 1:1 randomisation and four assess-
ments: pre-treatment, post-treatment and follow-ups 
after 4 weeks and 6 months. We embedded a follow-up of 
those informal carers who declined to participate. The 
study was approved by the Ethics Committee of Ludwig-
Maximilians-University of Munich (No: 545-12) and was 
registered with Clinical.Trials.gov (NCT02325167).
Sample and setting
Informal caregivers were recruited from the Munich 
University Hospital palliative care unit, Germany. Inclusion 
criteria were minimum age of 21 years and fluency in 
German. One caregiver per patient was included, prefer-
ably the person closest to the patient. Excluded were pro-
fessional legal representatives and caregivers with severe 
mental illness (e.g. dementia, acute addiction).
The sample size was calculated according to Fegg’s 
study:8 psychotherapy research reports treatment effects 
between 0.67 and 0.75 standard deviation (SD).11 To 
achieve a power of 0.8 at 5% significance level using Dupont 
What this paper adds?
•• EBT was shortened to two individual 1-h sessions (sEBT) to fit better into caregivers’ daily lives.
•• This randomised controlled trial tests the effectiveness of sEBT on psychological symptoms of informal caregivers in 
comparison with an active control.
Implications for practice, theory or policy
•• Shortening the intervention tripled inclusion rate to 41.0% reaching more caregivers.
•• Inclusion rate was traded for effectiveness and the intervention could not impact caregivers’ psychological state.
•• Early integration of sEBT and combination of individual and group setting are discussed.
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and Plummer’s12 sample size calculation and considering a 
dropout rate of 25%, 55 participants were needed in every 
arm of the study.
Recruiting procedure and randomisation
Caregivers were approached earliest after the day of the 
patient’s admission. They were screened for the inclusion 
criteria by psychologists with clinical experience. Potential 
participants were contacted in person or by phone and 
informed orally and in written form about the study. 
Caregivers who did not want to participate were asked to 
take part in the decliners’ follow-up. All participating car-
egivers and patients provided written informed consent. 
Consent of a legal guardian was sought for patients una-
ble to give consent.
Immediately after making the first appointment and 
receiving the first questionnaire, participants were ran-
domised by a randomisation list which was computer-
generated with blocks of 10, each containing five control 
and five sEBT assignments in random order. Participants 
were informed about their allocation in the first 
session.
The study was conducted on weekdays between January 
2015 and February 2018. Recruitment was suspended for 
5 months due to staff change (March 2016–August 2016) 
and three times due to staff vacation (21 December 2016–9 
January 2017; 2 August 2017–8 September 2017; 22 
December 2017–8 January2018).
Intervention
sEBT and control intervention both comprised two ses-
sions in an individual setting lasting 45–60 min; appoint-
ments were arranged individually. The interventions took 
place in a separate room in the palliative care unit and in 
a psychotherapeutic practice. Three psychologists with 
several years of experience in behavioural psychotherapy 
were trained using video feedback. sEBT and control 
group sessions were audiotaped and rated for treatment 
integrity using coding guidelines and checklists (range 
0–4: ‘0’ = element missing to ‘4’ = fully consistent with 
the manual).
Control group. The active control group was oriented 
towards Carl Rogers’13 client-centred therapy, characterised 
by acceptance, congruence and empathic understanding, 
as recommended in supporting informal caregivers in a 
palliative setting.14 There was no mention of mindfulness 
or resources.
sEBT group. The first sEBT session focussing on mindful-
ness included: introduction, psychoeducation about 
mindfulness, 2-min body scan, 10-min mindful breathing 
exercise, addressing questions and motivation to practice 
mindfulness every day using a CD provided.
The second sEBT session focussing on resources 
included: introduction, psychoeducation on psychological 
meaning of resources, encouragement to express 
strengthening areas and activities (based on Schedule for 
Meaning in Life Interview15), imaginative exercise of the 
inner image of the strongest resource addressing all five 
senses, choice of a symbol as reminder and prime, 
addressing questions, motivation to practice mindful 
breathing and imaginative exercise using the CD.
Data collection
Caregivers’ demographic data and patients’ medical data 
were collected through self-report and clinic chart review. 
Participants of the randomised controlled trial completed 
standardised questionnaires at the time of study entry (t1), 
after the second intervention session (t2) and 4 weeks (t3) 
and 6 months (t4) after the second intervention session.
Participants of the decliners’ follow-up received three 
questionnaires: at t1 and follow-ups 4 weeks (t3) and 
6 months (t4) after t1, with no decliner questionnaire at t2.
Measurement instruments
All measurement instruments were used in a validated 
German version.
Primary outcome. Level of depression was measured 
with Patient Health Questionnaire, 9 items; a score >15 is 
associated with clinical levels of depression, and scores 
are sums ranging from 0 to 27.16,17
Secondary outcomes. Generalised anxiety disorder was 
assessed using the Generalised Anxiety Disorder Ques-
tionnaire, 7 items; a score >10 indicates general anxiety 
disorder, and scores are sums ranging from 0 to 21.18,19
Subjective distress was measured using the National 
Comprehensive Cancer Network’s Distress Thermometer; a 
score >5 indicates a clinically relevant level of distress, 
scale range 0–10, from ‘No distress’ to ‘Extreme distress’.20
Minor mental disorders were assessed using the 
General Health Questionnaire, 12 items, with higher 
scores indicating higher level of mental disorder; scores 
are sums of item values ranging from 0 to 36.21,22
Positive and negative affect were measured using the 
Positive and Negative Affect Schedule, with higher scores 
indicating higher levels of affect; scores ranging from 1 to 5 
are means of positive and negative items, respectively.23,24
Life satisfaction was measured using the Satisfaction 
with Life Scale, with higher scores indicating higher degree 
of satisfaction; scores are sums of item values ranging 
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Quality of life was assessed using the World Health 
Organization Quality of Life Questionnaire, abbreviated 
version: scores range from 0 to 100, with higher scores 
denoting higher quality of life; scores were built according 
to the manual guidelines, including handling of missing 
data.27,28
Health-related resource use of the past 6 months 
(number of physician contacts, physiotherapist contacts, 
hospital days, and rehabilitation days) was collected using 
the German questionnaire for health-related resource use 
in an elderly population (at t1 and t4).29 Individual costs 
were added up after assigning a cost to each component 
based on unit prices published by Bock et al.30
Three numerical rating scales with one item each 
measured quality of life, physical impairment and psycho-
logical impairment, with scores ranging from 0 to 10, with 
higher scores indicating higher levels. Of all the used 
scales, only in the manual of the World Health Organization 
Quality of Life Questionnaire,27,28 guidelines on how to 
treat missing data were provided: Outcomes were only 
computed if at least 80% of the items in a scale were avail-
able and the missing items were imputed with the mean 
of the available items. Otherwise the whole observation 
was discarded. For consistency, we applied this approach 
to all scales.
Factors of the health belief model. Rosenstock’s Health 
Belief Model, designed to predict health-promoting 
behaviour, was employed in order to understand reasons 
for declining.31,32 The following four factors of the Health 
Belief Model each comprised several variables and were 
included in questionnaires for decliners and for the ran-
domised controlled trial.
‘Modifying factors’: age, gender, knowledge about 
depression (numerical rating scale ranging from 0 to 10) 
and self-efficacy (German general self-efficacy short scale) 
scores are means ranging from 1 to 5, with higher scores 
indicating higher levels.33
Factor ‘perceived susceptibility and severity’: two 
numerical rating scales with 0–10 ranges on susceptibility 
for and severity of suffering from depression.
Factor ‘perceived benefits and barriers’: four numeri-
cal rating scales on scepticism of benefit of the interven-
tion (adapted from Patient Questionnaire on Therapy 
Expectation and Evaluation,34 1–5 range), belief in bene-
fit (adapted from German questionnaire for measure-
ment of psychotherapy motivation,35 1–5 range), belief 
one should cope alone (adapted from German question-
naire for psychotherapy motivation,36 1–4 range), and 
belief that the intervention benefit would be greater 
than the costs (1–4 range). Higher scores indicate higher 
agreement.
Factor ‘cues to action’: three numerical rating scales on 
advice from family/friends to accept psychological sup-
port, the extent of support by family/friends and the 
quality of the relationship with the patient, with higher 
scores indicating higher levels.
Statistical analysis
Changes in the outcomes over time were evaluated via 
general linear mixed model with random intercept for 
subjects. These models allowed several measurements 
per participant and change over time. A separate regres-
sion model was built for each outcome measure.
Outcomes from all three post-treatment question-
naires (t2, t3, t4) were dependent variables. Variables 
‘group’ (sEBT or control group) and ‘time of investigation’ 
were independent variables. The interaction effect 
between ‘group’ and ‘time of investigation’ was only 
included if significantly different from zero. The pre-treat-
ment (t1) value of each outcome measure was included as 
a predictor variable, capturing individual status before the 
treatment. In all models, we controlled for age, gender, 
relationship with the patient (patient is partner/child vs 
other); patient’s time of death (patient alive, unknown, 
deceased >3 months before measurement, <3 months 
before measurement); employment (employed/student 
vs retired/unemployed); the psychologist delivering the 
intervention (psychologist 1, 2 or 3); and other support 
used (e.g. social worker, pastoral care, other psychologist; 
yes, no or unknown).
Besides the main model (model 1), we conducted sen-
sitivity analyses considering the following two subgroups 
of the study population: only participants (sEBT or control 
group) who attended both interventional sessions (model 
2) and all control participants and only sEBT participants 
who had practised mindfulness at least once using the CD 
(model 3). Sensitivity analyses controlling for missing data 
were also conducted.
Data were analysed according to the principle ‘full 
analysis set’ which is as complete and as close as possi-
ble to the intention to treat ideal of including all ran-
domised subjects.37 The regression analyses included 
only individuals with at least one intervention session 
and participation in the investigations before (t1) and 
after the intervention (t2).
A binary logistic regression was conducted to investi-
gate which factors led to declining or accepting the inter-
vention. Based on Rosenstock’s31 Health Belief Model, 
stepwise inclusion of four factors emulated the process of 
decision-making for or against the intervention. An overall 
result was deduced from all four steps. In addition, linear 
mixed models with repeated measurements were used to 
model all outcome parameters at t1, t3 and t4 in order to 
detect differences in outcomes between the participants 
of the randomised controlled trial and the decliner partici-
pants. To analyse differences in direct health care costs, 
the non-parametric Mann–Whitney U test was used due 
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were performed using IBM SPSS statistics V.25; a value of 
p < 0.05 was considered significant; a value of p < 0.1 
was considered a trend.
Results
Results are reported following the CONSORT statement.
Study population
Out of 722 potential participants, 227 were excluded 
during recruitment (31.4%; see Figure 1), hence 495 car-
egivers were contacted (68.6%). Of these, 67 partici-
pated in the decliners’ follow-up and 225 declined any 
participation. A total of 203 caregivers were randomised 
into the sEBT or the control group; the inclusion rate 
was 41.0%. During the study, 10 cases were excluded as 
they had been wrongfully assigned. After the randomi-
sation, 36 participants dropped out before t1 (20 sEBT, 
16 controls).
In total, 157 participants of the randomised controlled 
trial took part in the pre-intervention examination (t1). At 
t1, sEBT and control participants showed no significantly 
different characteristics (see Table 1). The mean age was 
54.6 years (SD 14.1) and most participants were female 
(63.1%). More than one-third of the participants held a 
university degree (38.2%), more than half were married 
(59.2%); nearly one-third was retired (29.9%) and two-
thirds employed (full time 42.7%, part time 22.0%). 
Participants were mostly either patients’ partners (includ-
ing wives or husbands; 39.5%) or their children (36.9%). 
Cancer was the prevailing diagnosis of the patients 
(79.5%). Two-thirds of participants received interventions 
by psychologist 3 (66.2%). Most patients were alive at t1 
(84.7%; 7.0% deceased ⩽3 months ago; 8.3% unknown; 
n = 157). At t2, patients were mostly alive (49.6%) or had 
deceased during the last 3 months (43.3%; 7.1% unknown; 
n = 127). At t3, most patients had deceased during the last 
3 months (73.7%; 17.2% alive; 4.1% deceased >3 months 
ago; 4.9% unknown; n = 122), and at t4, most patients had 
Figure 1. CONSORT diagram of participant flow.
aDue to missing data at t2, participants’ datasets were excluded from analyses.
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Table 1. Participant characteristics by randomised controlled trial and decliners’ follow-up.
Randomised controlled trial Decliners (N = 50)
 sEBT (N = 75) Control (N = 82)
Age (mean, SD) 53.8 (15.2) 55.3 (13.0) 60.9 (13.1)
Female 51 (68.0%) 48 (58.5%) 33 (66.0%)
Religion
 Catholic 29 (38.7%) 31 (37.8%) 20 (40.0%)
 Protestant 17 (22.7%) 19 (23.2%) 10 (20.0%)
 Muslim 1 (1.3%) 2 (2.4%) 2 (4.0%)
 Other 5 (6.7%) 1 (1.1%) 2 (4.0%)
 None 19 (25.3%) 27 (32.9%) 14 (28.0%)
 No data 2 (2.7%) 2 (2.4%) 2 (4.0%)
Education
 University degree 26 (34.7%) 34 (41.5%) 13 (26.0%)
 Upper secondary 14 (18.7%) 7 (8.5%) 5 (10.0%)
 Intermediate secondary 25 (33.3%) 27 (32.9%) 16 (32.0%)
 Lower secondary 10 (13.3%) 10 (12.2%) 15 (30.0%)
 None/no data – – 2 (4.9%) 1 (2.0%)
Marital status
 Married 42 (56.0%) 51 (62.2%) 36 (72.0%)
 In relationship 16 (21.3%) 16 (19.5%) 8 (16.0%)
 Single 8 (10.7%) 5 (6.1%) 1 (2.0%)
 Divorced/separated 6 (8.0%) 6 (7.3%) 3 (6.0%)
 Widowed 2 (2.7%) 4 (4.9%) 2 (4.0%)
 No data 1 (1.3%)  
Employment
 Full time 27 (36.0%) 40 (48.8%) 23 (46.0%)
 Part time (<35 h) 18 (24.0%) 15 (18.3%) 6 (12.0%)
 Student/vocational 4 (5.3%) 1 (1.2%) – –
 Retired 24 (32.0%) 23 (28.0%) 20 (40.0%)
 Homemaker/unemployed 2 (2.7%) 3 (3.7%) 1 (2.0%)
Relationship with patient (Patient is my . . .)
 Wife/husband/partner 29 (38.7%) 33 (40.2%) 27 (54.0%)
 Mother/father 27 (36.0%) 31 (37.8%) 18 (36.0%)
 Daughter/son 5 (6.7%) 2 (2.4%) – –
 Sister/brother 5 (6.7%) 6 (7.3%) 4 (8.0%)
 Friend 5 (6.7%) 4 (4.9%) – –
 Grandmother/grandfather 1 (1.3%) 1 (1.2%) – –
 Other 3 (4.0%) 5 (6.1%) 1 (2.0%)
Diagnosis of patient
 Digestive tract cancer 17 (22.7%) 14 (17.1%) 7 (14.0%)
 Genito-urinary cancer 10 (13.3%) 4 (4.9%) 7 (14.0%)
 Breast cancer 10 (13.3%) 7 (8.5%) 4 (8.0%)
 Brain cancer 6 (8.0%) 7 (8.5%) 2 (4.0%)
 Lung cancer 7 (9.3%) 11 (12.6%) 9 (18.0%)
 Gynaecological cancer 4 (5.3%) 10 (12.2%) 4 (8.0%)
 Other cancer 5 (6.7%) 15 (18.3%) 5 (10.0%)
 Neurological disease 7 (9.3%) 6 (7.3%) 9 (18.0%)
 Other disease 9 (12.0%) 10 (12.2%) 3 (6.0%)
Psychologist delivering the intervention
 Psychologist 1 14 (18.7%) 14 (17.1%) – –
 Psychologist 2 12 (16.0%) 13 (15.9%) – –
 Psychologist 3 49 (65.3%) 55 (67.1%) – –
SD: standard deviation.
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deceased more than 3 months ago (83.9%; 3.4% deceased 
⩽3 months ago; 6.8% alive; 5.9% unknown; n = 118; see 
Supplemental Material Appendix A).
Thirty participants of the pre-intervention examination 
(t1) were not included in the main data analysis because 
they dropped out during the intervention or had missing 
data at t2 (see Figure 1). An independent-sample t-test 
indicated that these drop-outs had higher levels of nega-
tive affect at t1 (mean: 2.58, SD: 0.61) than participants 
included in the main analysis (mean: 2.22, SD: 0.68; 
p-value: 0.010), and they tend to higher levels of minor 
mental disorders (mean: 1.48, SD: 0.46) than participants 
included in the main analysis (mean: 1.30, SD: 0.45; 
p-value: 0.058; unequal variances). They did not signifi-
cantly differ in any other outcome or characteristic.
A total of 127 participants were included in the main 
regression analysis (model 1) according to the principle of 
‘full analysis set’ as they participated in at least the first 
two investigations at t1 and t2. These participants showed 
mild and subclinical levels of depression at t1 (mean: 8.79, 
SD: 5.20). The sample’s average score on anxiety was just 
under the cut-off for clinically relevant levels (mean: 9.69, 
SD: 4.77). Their average level of distress was above the 
score indicating clinical relevance (mean: 7.50, SD: 2.00).
At t3, 122 datasets were available and included in anal-
yses. At t4, 118 datasets were available and included.
The percentage of scales with at least one missing item 
was 7.49%. By including observations which had at least 
80% of items completed, we were able to lower the num-
ber of scales that had to be discarded to 3.74%.
Treatment integrity
In total, 291 intervention sessions were held (sEBT and 
control, including dropouts), 29 participants received only 
one session. 274 audiotapes of the intervention sessions 
were available (94.2%), eight were incomplete and not 
rated; five participants declined consent for audiotaping. 
266 audiotapes were rated to evaluate treatment integ-
rity. The therapists’ adherence to the intervention manual 
was high (sEBT mean: 3.80, SD: 0.36; control mean: 3.87, 
SD: 0.33).
Primary outcome
The level of depression did not differ significantly between 
sEBT and control group (sEBT beta: –.147; control group as 
reference category); this was true for all three models 
(see Table 2). Apart from the impact of pre-treatment 
depression, there was a trend for the time of investigation 
being associated with the post-treatment depression level 
(t3 beta: –.796; t4 beta: –1.32; t2 as reference category), 
Table 2. Estimated regression coefficients beta and p-values for the independent variables in general linear mixed models with the 
primary outcome variable post-treatment depression.
Variablea Categoryb Model 1 Model 2 Model 3
n = 126 n = 114 n = 104
Beta p-value Beta p-value Beta p-value
Gender Male –.457 0.407 –.293 0.627 –.588 0.325
Relationship with patient Partner/child –.666 0.283 –.553 0.413 –.897 0.185
Employment Retired/other –.645 0.443 –.259 0.777 .488 0.601
Support apart from study Unknown 1.40 0.365 1.32 0.408 2.01 0.231
 Support .599 0.403 .366 0.631 .789 0.325
Group sEBT intervention –.147 0.780 –.273 0.640 –.393 0.515
Time of investigation t3 –.796 0.031 –.957 0.016 –.984 0.021
 t4 –1.32 0.085 –1.72 0.036 –1.76 0.035
Patients’ time of death Unknown .574 0.616 .285 0.822 .194 0.871
 Alive –.381 0.421 –.490 0.335 –.623 0.245
 Deceased >3 months –1.02 0.183 –.900 0.270 –.882 0.277
Age .025 0.426 .013 0.695 –.005 0.873
Psychologist Psychologist 1 –.256 0.743 –.380 0.643 –.608 0.455
 Psychologist 2 .465 0.532 .312 0.695 .678 0.405
Depression at t1 .612 <0.001 .618 <0.001 .595 <0.001
Main model: participantsfirst two investigations (model 1); both sensitivity analyses include participants of at least the first two investigations of at 
least the : model 2 without participants (sEBT and control group) with only one session and model 3 without participants of the sEBT group who did 
not practise.
aVariables are in bold or bold italics depending on the significance of the F-test for the whole variable. Bold: significant at p-value < 0.05. Bold italics: 
p-value between 0.05 and 0.10 (trend).
bReference categories: gender – female; relationship with patient – other; employment – employment/student; support apart from study – no sup-
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as depression was on average lower at t3 and t4 than at 
t2. The interaction effect between the group and the time 
of investigation was not included in the main model since 
it was not significantly different from zero.
Secondary outcomes
According to the results of the main models, all post-
treatment secondary outcomes did not significantly differ 
between sEBT and control group (for tables see 
Supplemental Material Appendix B). The interaction effect 
between the group (sEBT/control) and the time of investi-
gation was not included in the main models as it was not 
significantly different from zero, except for psychological 
impairment. Time of investigation was significantly associ-
ated with outcomes anxiety (t3 beta: –1.21; t4 beta: 
–1.67; t2 as reference category), positive affect (t3 beta: 
.158; t4 beta: .290) and minor mental disorders (t3 beta: 
.1.32; t4 beta: 2.96), and was associated by trend with 
negative affect (t3 beta: .127; t4 beta: .165) and quality of 
life (numerical rating scale; t3 beta: .444; t4 beta: .574).
Patients’ time of death was significantly associated 
with outcomes negative affect (alive beta: .066; deceased 
>3 months ago beta: –.289; time of death unknown beta: 
.086; deceased ⩽3 months ago as reference category), 
satisfaction with life (alive beta: –1.38; deceased 
>3 months ago beta: .984; time of death unknown beta: 
–1.70), subjective distress (alive beta: .424; deceased 
>3 months ago beta: –1.13; time of death unknown beta: 
.360) and psychological impairment (alive beta: .615; 
deceased >3 months ago beta: .456; time of death 
unknown beta: 1.83); patients’ time of death showed a 
trend to be associated with anxiety (alive beta: .011; 
deceased >3 months ago beta: –1.55; time of death 
unknown beta: .982). Relationship with the patient was 
significantly associated with quality of life (numerical rat-
ing scale; partner/child beta: –.680; other relationship as 
reference category). Age showed a trend to be associated 
with subjective distress (beta: .033) and gender showed a 
trend to be associated with psychological impairment 
(male beta: –.613 female gender as reference category).
In addition, we conducted sensitivity analyses regarding 
missing data (for tables see Supplemental Material Appendix 
C). Participants without missing items in any of the relevant 
outcome scales were regarded as having no missing data 
(n = 45, 35.4%); they were significantly younger than partici-
pants with missing data (n = 82). A variable discriminating 
between these two groups was added to an additional set of 
regression analyses. These analyses yielded highly similar 
results compared the analyses described above, apart from 
the variable missing data being associated by trend with 
negative affect (no missing data beta: .155).
At t1, a Mann–Whitney U test showed that, at t1, there 
was no significant difference between the median of 
direct health care costs for the past 6 months of sEBT par-
ticipants (median: €450, n = 51, interquartile range: 846.4) 
and controls (median: €328, n = 62, interquartile range: 
558.8).
At t4, there was also no significant difference between 
the median of direct health care costs for the previous 
6 months of sEBT participants (median: €224, n = 54, 
interquartile range: 560.2) and controls (median: €301, 
n = 64, interquartile range: 829.9).
Decliners’ follow-up
Data of 50 decliners were available at t1, as 17 dropped 
out before t1. Data of 43 decliners were available for the 
follow-up at t3 and data of 38 decliners at t4. Declining 
participants were significantly older (mean: 60.9 years, 
SD: 13.1) than participants of the randomised controlled 
trial (mean: 54.6, SD: 14.1) but did not significantly differ 
regarding gender, relationship status or employment.
Linear mixed models with repeated measurements mod-
elling all outcome parameters at t1, t3 and t4 showed no 
differences in any outcomes between the participants of the 
randomised controlled trial and the decliner participants.
The binary logistic regression showed that the prefer-
ence towards the decliner study significantly depends on 
‘perceived benefit and barriers’ and ‘cues to action’ (see 
Table 3). The odds to prefer the decliners’ follow-up were 
2.45 times higher for caregivers with high self-efficacy 
(95% confidence interval: 1.06–5.65), 1.71 times higher 
when being sceptic of the benefit of the intervention (95% 
confidence interval: 1.12–2.61), 2.21 times higher for car-
egivers who believed in better coping alone (95% confi-
dence interval: 1.28–3.81) and 1.30 times higher for 
caregivers supported by family and friends (95% confi-
dence interval 1.01–1.69).
Discussion
Main findings of the study
The purpose of sEBT is to provide a short-term interven-
tion with coping strategies to informal caregivers of pallia-
tive patients facing the existential situation of disease and 
bereavement. This randomised controlled trial studied 
the impact of sEBT on depression, anxiety, subjective dis-
tress, minor mental disorders, positive and negative 
affect, satisfaction with life, quality of life and direct 
health care costs. Receiving sEBT sessions or supportive 
psychological sessions was neither significantly associated 
with the primary outcome of post-treatment depression 
nor with the secondary outcomes. The outcomes were 
prevailingly associated with their respective level before 
the intervention and with the time of investigation, which 
leads to the assumption that the time passing was the 
main reason for changes of outcomes over the course of 
6 months. Caregivers who declined the intervention did 
not differ significantly from participants of the randomised 
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Interpretation of results
In Fegg et al’.s8 randomised controlled trial on EBT, the 
control participants did not receive a control treatment 
and instead could decline any support or could choose 
from the spectrum of available support at the palliative 
care unit (e.g. physicians, nurses, chaplains, social work-
ers, psychologists and bereavement group), whereas this 
study included an active control group. It is possible that 
sEBT and control showed no significant difference as both 
groups received a treatment of similar effectiveness.
Palliative caregivers’ capacities for learning new skills 
like mindfulness might be limited: they face high emo-
tional distress and the responsibilities palliative care-
givers typically take over for the patient (i.e. financial 
decisions, organisation of follow-up hospice care) addi-
tionally to their own duties. Fegg et al’.s8 study provided 
a group setting which could have facilitated learning the 
new skill of mindfulness by benefitting from group cohe-
sion, central for beneficial effects in group therapy38,39 or 
by relieving participants from the personal responsibility 
to practice. Participants in sEBT were asked to practice 
mindfulness by themselves which was possibly too 
demanding, leading to low compliance to practice and 
less effectiveness.
Our aim was to create a short-term EBT intervention 
that fitted better into informal caregivers’ daily lives. We 
reached our goal of increasing acceptability: 41.0% of all 
contacted caregivers participated in the randomised con-
trolled trial. Shortening EBT and choosing an individual set-
ting tripled the inclusion rate compared with 13.6% in Fegg 
et al’.s8 study. However, by shortening the intervention, we 
traded inclusion rate for effectiveness and the intervention 
was not intensive enough to impact caregivers’ psychologi-
cal state in comparison to the control group.
Carmody and Baer’s40 review about the optimal length 
of mindfulness based programmes, with participants 
ranging from healthy to chronically ill participants, did not 
evidence that shortened versions of mindfulness-based 
programmes are less effective compared with the stand-
ard format of 26 class hours. The authors suggested that 
adaptations including less class time may be worthwhile 
for populations for whom a longer time commitment may 
be a barrier to participate.
But how short is too short? The study with the fewest 
sessions in Carmody and Baer’s40 review included 
6-weekly 1-h classes,41 which is three times more instruc-
tion time than in this study. Our results lead to the conclu-
sion that the 2-h sEBT version is too short, especially with 
participants as burdened as palliative caregivers. The opti-
mal length of mindfulness-based interventions for infor-
mal caregivers should be investigated further to offer 
interventions which impact caregivers’ psychological sta-
tus while not overwhelming them.
Strengths and limitations
Strengths of the study include the randomised controlled 
design, the high adherence of the therapists to the man-
ual and the embedded decliners’ follow-ups which 
allowed a comparison with trial participants and ensured 
high external validity.
Table 3. Preference for decliners’ follow-up or participation in the randomised controlled trial explained by ‘Health Belief Model’ 
comprising four factors (modifying factors, perceived susceptibility and severity, perceived benefit and barriers, and cues to action).






Age 1.02 .263 .99–1.06
Sex 1.81 .240 .67–4.89
Knowledge .98 .824 .82–1.17






Susceptibility 1.02 .865 .85–1.21
Severity .88 .124 .75–1.04





Scepticism of benefit 1.71 .013 1.12–2.61
Belief in benefit .81 .523 .42–1.55
Belief one should cope alone 2.21 .005 1.28–3.81
Belief that benefit > cost .77 .346 .44–1.34
Cues to action Fourth model
Nagelkerkes
R2 = .325
Advice from family/friends .98 .751 .84–1.13
Support by family/friends 1.30 .044 1.01–1.69
 Quality of relationship with Patient .97 .806 .76–1.24
CI = confidence interval.
Binary-logistic regression with stepwise inclusion of factors.
Coding of outcome: preference of decliners’ follow-up = 1; preference of randomised controlled trial = 0.
Coding of predictors: gender 0 = male, 1 = female; other predictors 0 = lowest level, 1 = highest level.
Bold values signifies p-value < 0.05.
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During the study, it became apparent that 10 partici-
pants had been assigned to sEBT or control group violat-
ing the randomisation protocol. Recruiting was suspended, 
all data collected up to this point was carefully checked 
and affected participants’ data were excluded from analy-
sis. In addition, appropriate measures of staff change and 
staff training were taken.
Data of 30 caregivers were removed from analysis as 
they had missing post-intervention data at t2 or dropped 
out of the intervention. Comparing their pre-intervention 
data to the other participants, they had higher levels of 
negative affect and of minor mental disorders which pos-
sibly caused them to drop out. This leads to the assump-
tion that the intervention might be too demanding for 
highly burdened caregivers.
Implications of our study and future research
Profiting of the ‘small window’6 for recruiting caregivers 
before they become too burdened by care could be facili-
tated with early integration of palliative care.42,43 Early 
integration of sEBT could help caregivers learn new skills 
to prepare for stressful times ahead.
Furthermore, sEBT could benefit from mixing the set-
tings. Sörensen et al.44 suggested combining group and 
individual setting to improve caregiver affect in the indi-
vidual setting and help build social networks in the group. 
Individual sEBT could offer immediate support to caregiv-
ers, while a following EBT group could yield higher impact 
on caregivers’ psychological morbidity with more class 
hours and positive influence of group cohesion38 on moti-
vation and personal practice.
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Table 5: Descriptive Characteristics of Staff Members who rated Caregiver Burden using ZBI-1 
(n=22) 
Characteristic n (%) or mean (SD) 
Setting   
 Palliative care unit 13 (59.1%) 
 Hospital support team 4 (18.2%) 
 Home care team 5 (22.7%) 
Age 36.5 (8.83) 
Sex   
 Female 16  (72.7%) 
Profession   
 Nursing staff 15 (68.2%) 
 Medical staff 7 (31.8%) 
Years of professional experience 13.3 (10.5) 
Years of experience in palliative care 3.3 (4.6) 
Number of Zarit-Ratings 3.6 (2.6) 





























ZBI-7 1 84 
X² = 20.255, df = 14           p 
= 0.122 





X² = 23.782, df = 14                 
p = 0,058 
0.00 (0.61) -0.87 (1.15) 0.79 
ZBI-6 3 77 
X² = 16.418, df = 12               
p = 0.173 
0.00 (0.43) -0.84 (0.92) 0.69 
ZBI-1 4 84 
X² = 3.106, df = 4                p 
= 0.540 






Figure 2: Person-Item Threshold Distribution of Rasch Analysis for ZBI-7 
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Appendix 2.1 Time of death of patients 
 
Table 4: Time of death of patients during caregivers’ participation in the study. 
 RCT  
Time of death of the patient sEBT Control Decliners 
At t1 n = 75 n = 82 n =50 
 Unknown 3 (4.0%) 10 (12.2%) 7 (14.0%) 
 Alive 66 (88.0%) 67 (81.7%) 37 (74.0%) 
 Died ≤ 3 months ago 6 (8.0%) 5 (6.1%) 5 (10.0%) 
 Died ≥ 3 months ago - - - - 1 (2.0%) 
        
At t2 n = 60 n = 67  
 Unknown 2 (3.3%) 7 (10.4%)   
 Alive 31 (51.7%) 32 (47.8%)   
 Died ≤ 3 months ago 27 (45.0%) 28 (41.8%)   
        
At t3 n = 58 n = 64 n = 43 
 Unknown 1 (1.7.0%) 5 (7.8%) 11 (22.0%) 
 Alive 12 (20.7%) 9 (14.1%) 8 (16.0%) 
 Died ≤ 3 months ago 43 (74.1%) 47 (73.4%) 29 (58.0%) 
 Died ≥ 3 months ago 2 (3.4%) 3 (4.7%) 2 (4.0%) 
        
At t4 n = 54 n = 64 n =38 
 Unknown 1 (1.9%) 6 (9.4%) 16 (32.0%) 
 Alive 4 (7.4%) 4 (6.3%) 2 (4.0%) 
 Died ≤ 3 months ago 3 (5.6%) 1 (1.6%) 1 (2.0%) 
 Died ≥ 3 months ago 46 (85.2%) 53 (82.8%) 31 (62.0%) 
Note: Data are number (%) 
No data for decliners at t2 
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   Model 1  Model 2  Model 3 
Variable a Category b  n= 126  n= 114  n= 104 
   beta p-Value  beta p-Value  beta p-Value 
Gender Male  -.783 .184  -.573 .374  -.824 .208 
Relationship with patient  Partner/child  .015 .981  .078 .912  -.245 .732 
Employment Retired/other  .125 .888  .407 .672  1.27 .207 
Support apart from study Unknown  1.74 .295  1.85 .285  2.73 .136 
 Support  .380 .617  .418 .607  .847 .334 
Group sEBT intervention  -.318 .569  -.580 .346  -.914 .162 
Time of investigation t3  -1.21 .003  -1.23 .006  -1.40 .002 
 t4  -1.67 .022  -1.76 .026  -2.25 .005 
Patient’s time of death Unknown  .982 .473  .488 .717  .362 .784 
 Alive  .011 .983  .105 .856  -.447 .453 
 Deceased >3 months  -1.55 .030  -1.58 .040  -1.27 .103 
Age   -.006 .859  -.015 .664  -.039 .278 
Psychologist  Psychologist 1  -.109 .895  -.067 .939  -.356 .687 
 Psychologist 2  -.504 .517  -.583 .484  -.393 .650 
Anxiety at t1  .565 <.001  .553 <.001  .502 <.001 
 
Table 5: Estimated regression coefficients beta and p-values for the independent variables in general linear mixed models with the 
secondary outcome variable post-treatment anxiety. Main model: participants of at least the first two investigations (model 1); 
both sensitivity analyses include participants of at least the first two investigations, model 2 without participants (sEBT and 
control group) with only one session, model 3 without participants of the sEBT group who did not practise. 
a Variables are in bold or bold italics depending on the significance of the F-test for the whole variable. Bold: significant at p-
value<0.05.  Bold italics: p-value between 0.05 and 0.10 (trend). 
b Reference categories: Gender – Female; Relationship with Patient – Other; Employment – Employment/Student; Support apart 
from study – No support; Group – Control; Time of investigation – t2; Patient deceased – Deceased ≤ 3 months; Psychologist – 
Psychologist 3. 




















   Model 1  Model 2  Model 3 
Variable a Category b  n= 124  n= 112  n= 102 
   beta p-Value  beta p-Value  beta p-Value 
Gender Male  .323 .313  .497 .132  .376 .288 
Relationship with patient  Partner/child  .508 .155  .748 .042  .310 .428 
Employment Retired/other  .272 .566  .457 .345  .884 .100 
Support apart from study Unknown  -.309 .731  -.490 .575  .617 .529 
 Support  .426 .297  .201 .623  .687 .142 
Group sEBT intervention  -.014 .964  -.211 .507  -.084 .814 
Time of investigation t3  -.341 .157  -.447 .083  -.441 .117 
 t4  -.838 .112  -1.02 .070  -.982 .101 
Patient’s time of death Unknown  .360 .588  -.053 .939  .003 .996 
 Alive  .424 .175  .271 .405  .293 .412 
 Deceased >3 months  -1.13 .032  -1.02 .067  -1.13 .053 
Age   -.033 .060  -.044 .014  -.051 .008 
Psychologist Psychologist 1  -.451 .309  -.637 .145  -.689 .144 
 Psychologist 2  -.007 .987  -.099 .826  -.086 .861 
Subjective distress at t1  .405 <.001  .385 <.001  .450 <.001 
 
Table 6: Estimated regression coefficients beta and p-values for the independent variables in general linear mixed models with the 
secondary outcome variable post-treatment subjective distress. Main model: participants of at least the first two investigations 
(model 1); both sensitivity analyses include participants of at least the first two investigations, model 2 without participants 
(sEBT and control group) with only one session, model 3 without participants of the sEBT group who did not practise. 
a Variables are in bold or bold italics depending on the significance of the F-test for the whole variable. Bold: significant at p-
value<0.05.  Bold italics: p-value between 0.05 and 0.10 (trend). 
b Reference categories: Gender – Female; Relationship with Patient – Other; Employment – Employment/Student; Support apart 
from study – No support; Group – Control; Time of investigation – t2; Patient deceased – Deceased ≤ 3 months; Psychologist – 
Psychologist 3. 




















   Model 1  Model 2  Model 3 
Variable a Category b  n= 122  n= 110  n= 100 
   beta p-Value  beta p-Value  beta p-Value 
Gender Male  -.045 .595  -.128 .153  -.098 .312 
Relationship with patient  Partner/child  -.094 .311  -.175 .077  -.015 .885 
Employment Retired/other  -.072 .566  -.123 .348  -.175 .233 
Support apart from study Unknown  -.186 .421  -.168 .465  -.220 .404 
 Support  .097 .384  .164 .153  .190 .153 
Group sEBT intervention  .018 .822  .044 .603  .065 .495 
Time of investigation t3  .158 .004  .172 .003  .211 .001 
 t4  .290 .033  .317 .025  .357 .017 
Patient’s time of death Unknown  -.016 .927  .047 .791  .022 .904 
 Alive  .083 .251  .094 .215  .064 .421 
 Deceased >3 months  .110 .413  .045 .741  .105 .464 
Age   -.002 .672  .002 .678  -.001 .876 
Psychologist Psychologist 1  .074 .528  .107 .365  .091 .477 
 Psychologist 2  .124 .285  .122 .303  .041 .750 
Positive affect at t1   .677 <.001  .637 <.001  .679 <.001 
 
Table 7: Estimated regression coefficients beta and p-values for the independent variables in general linear mixed models with the 
secondary outcome variable post-treatment of positive affect. Main model: participants of at least the first two investigations 
(model 1); both sensitivity analyses include participants of at least the first two investigations, model 2 without participants 
(sEBT and control group) with only one session, model 3 without participants of the sEBT group who did not practise. 
a Variables are in bold or bold italics depending on the significance of the F-test for the whole variable. Bold: significant at p-
value<0.05.  Bold italics: p-value between 0.05 and 0.10 (trend). 
b Reference categories: Gender – Female; Relationship with Patient – Other; Employment – Employment/Student; Support apart 
from study – No support; Group – Control; Time of investigation – t2; Patient deceased – Deceased ≤ 3 months; Psychologist – 
Psychologist 3. 




















   Model 1  Model 2  Model 3 
Variable a Category b  n= 122  n= 110  n= 100 
   beta p-Value  beta p-Value  beta p-Value 
Gender Male  .049 .536  .096 .274  .082 .350 
Relationship with patient  Partner/child  .119 .163  .160 .090  .072 .445 
Employment Retired/other  .147 .213  .176 .171  .304 .023 
Support apart from study Unknown  .201 .358  .192 .398  .330 .168 
 Support  -.076 .469  -.105 .350  -.014 .905 
Group sEBT intervention  -.080 .288  -.082 .320  -.112 .202 
Time of investigation t3  -.127 .021  -.117 .051  -.120 .053 
 t4  -.165 .124  -.188 .111  -.174 .135 
Patient’s time of death Unknown  .086 .599  .094 .601  .065 .707 
 Alive  -.066 .360  -.058 .464  -.082 .292 
 Deceased >3 months  -.289 .008  -.263 .027  -.278 .018 
Age   -.005 .237  -.007 .167  -.010 .035 
Psychologist Psychologist 1  -.147 .182  -.163 .160  -.199 .089 
 Psychologist 2  .028 .795  .045 .696  .102 .393 
Negative affect at t1   .531 <.001  .543 <.001  .504 <.001 
 
Table 8: Estimated regression coefficients beta and p-values for the independent variables in general linear mixed models with the 
secondary outcome variable post-treatment negative affect.  Main model: participants of at least the first two investigations 
(model 1); both sensitivity analyses include participants of at least the first two investigations, model 2 without participants 
(sEBT and control group) with only one session, model 3 without participants of the sEBT group who did not practise. 
a Variables are in bold or bold italics depending on the significance of the F-test for the whole variable. Bold: significant at p-
value<0.05.  Bold italics: p-value between 0.05 and 0.10 (trend). 
b Reference categories: Gender – Female; Relationship with Patient – Other; Employment – Employment/Student; Support apart 
from study – No support; Group – Control; Time of investigation – t2; Patient deceased – Deceased ≤ 3 months; Psychologist – 
Psychologist 3. 




















   Model 1  Model 2  Model 3 
Variable a Category b  n= 126  n= 114  n= 104 
   beta p-Value  beta p-Value  beta p-Value 
Gender Male  -.090 .898  .447 .543  .050 .950 
Relationship with patient Partner/child  1.25 .113  1.79 .030  .835 .335 
Employment Retired/other  -1.53 .151  -.896 .413  -.773 .523 
Support apart from study Unknown  1.90 .339  1.75 .368  3.07 .162 
 Support  .794 .384  .420 .649  .650 .533 
Group sEBT intervention  -.405 .548  -.683 .349  -.825 .295 
Time of investigation t3  -1.32 .009  -1.64 .003  -1.62 .006 
 t4  -2.96 .010  -3.30 .008  -3.54 .006 
Patient’s time of death Unknown  -.869 .555  -1.68 .274  -1.44 .366 
 Alive  -.915 .165  -1.30 .059  -1.32 .082 
 Deceased >3 months  -1.49 .206  -1.28 .310  -1.35 .293 
Age   .032 .431  .001 .989  .014 .750 
Psychologist  Psychologist 1  .062 .950  -.062 .950  -.441 .677 
 Psychologist 2  -.162 .864  -.296 .757  -.193 .855 
Minor mental disorders at t1   .598 <.001  .606 <.001  .579 <.001 
 
Table 9: Estimated regression coefficients beta and p-values for the independent variables in general linear mixed models with the 
secondary outcome variable post-treatment minor mental disorders. Main model: participants of at least the first two 
investigations (model 1); both sensitivity analyses include participants of at least the first two investigations, model 2 without 
participants (sEBT and control group) with only one session, model 3 without participants of the sEBT group who did not 
practise. 
a Variables are in bold or bold italics depending on the significance of the F-test for the whole variable. Bold: significant at p-
value<0.05.  Bold italics: p-value between 0.05 and 0.10 (trend). 
b Reference categories: Gender – Female; Relationship with Patient – Other; Employment – Employment/Student; Support apart 
from study – No support; Group – Control; Time of investigation – t2; Patient deceased – Deceased ≤ 3 months; Psychologist – 
Psychologist 3. 




















   Model 1  Model 2  Model 3 
Variable a Category b  n= 126  n= 114  n= 104 
   beta p-Value  beta p-Value  beta p-Value 
Gender Male  -.105 .887  -.356 .654  .176 .824 
Relationship with patient  Partner/child  -.226 .781  -.149 .865  .077 .930 
Employment Retired/other  -.605 .583  -.1.39 .238  -2.28 .063 
Support apart from study Unknown  -.014 .995  .150 .942  -2.59 .245 
 Support  -.372 .693  -.236 .811  -.508 .633 
Group sEBT intervention  -.137 .842  .061 .934  .668 .393 
Time of investigation t3  -.472 .232  -.313 .456  -.269 .549 
 t4  -.608 .479  -.357 .698  -.233 .808 
Patient’s time of death Unknown  -1.70 .255  -1.23 .444  -1.19 .448 
 Alive  -1.38 .014  -1.05 .077  -1.38 .031 
 Deceased >3 months  .984 .247  .737 .419  .925 .318 
Age   .012 .774  .034 .428  .038 .391 
Psychologist Psychologist 1  .463 .652  .508 .630  1.05 .328 
 Psychologist 2  -.118 .902  -.059 .953  -.521 .611 
Satisfaction with life at t1   .643 <.001  .660 <.001  .607 <.001 
 
Table 10: Estimated regression coefficients beta and p-values for the independent variables in general linear mixed models with 
the secondary outcome variable post-treatment satisfaction with life. Main model: participants of at least the first two 
investigations (model 1); both sensitivity analyses include participants of at least the first two investigations, model 2 without 
participants (sEBT and control group) with only one session, model 3 without participants of the sEBT group who did not 
practise. 
a Variables are in bold or bold italics depending on the significance of the F-test for the whole variable. Bold: significant at p-
value<0.05.  Bold italics: p-value between 0.05 and 0.10 (trend). 
b Reference categories: Gender – Female; Relationship with Patient – Other; Employment – Employment/Student; Support apart 
from study – No support; Group – Control; Time of investigation – t2; Patient deceased – Deceased ≤ 3 months; Psychologist – 
Psychologist 3. 



















   Model 1  Model 2  Model 3 
Variable a Category b  n= 126  n= 114  n= 104 
   beta p-Value  beta p-Value  beta p-Value 
Gender Male  -4.08 .102  -5.69 .030  -3.95 .155 
Relationship with patient  Partner/child  -1.33 .630  -.904 .752  -1.58 .609 
Employment Retired/other  1.87 .620  -.362 .925  1.23 .777 
Support apart from study Unknown  -4.75 .510  -6.23 .375  -8.53 .285 
 Support  -1.05 .743  -1.55 .633  -2.96 .428 
Group sEBT intervention  -2.16 .360  -1.12 .647  -3.13 .266 
Time of investigation t3  .837 .665  1.27 .508  2.13 .297 
 t4  -.800 .862  -.083 .986  -.466 .923 
Patient’s time of death Unknown  -.833 .873  -.449 .933  .261 .962 
 Alive  .186 .941  1.36 .588  .595 .826 
 Deceased >3 months  4.75 .314  5.40 .257  5.89 .225 
Age   -.141 .324  -.127 .377  -.132 .411 
Psychologist Psychologist 1  -1.74 .622  -3.00 .394  -1.11 .769 
 Psychologist 2  -2.99 .369  -3.18 .344  -1.96 .597 
Quality of life (World Health Organisation) at 
t1 
 .451 <.001  .518 <.001  .467 <.001 
 
Table 11: Estimated regression coefficients beta and p-values for the independent variables in general linear mixed models with 
the secondary outcome variable post-treatment quality of life (World Health Organisation). Main model: participants of at least 
the first two investigations (model 1); both sensitivity analyses include participants of at least the first two investigations, model 2 
without participants (sEBT and control group) with only one session, model 3 without participants of the sEBT group who did not 
practise. 
a Variables are in bold or bold italics depending on the significance of the F-test for the whole variable. Bold: significant at p-
value<0.05. Bold italics: p-value between 0.05 and 0.10 (trend). 
b Reference categories: Gender – Female; Relationship with Patient – Other; Employment – Employment/Student; Support apart 
from study – No support; Group – Control; Time of investigation – t2; Patient deceased – Deceased ≤ 3 months; Psychologist – 
Psychologist 3. 



















   Model 1  Model 2  Model 3 
Variable a Category b  n= 123  n= 111  n= 102 
   beta p-Value  beta p-Value  beta p-Value 
Gender Male  -.425 .176  -.669 .047  -.413 .248 
Relationship with pat.  Partner/child  -.680 .047  -.804 .028  -.459 .235 
Employment Retired/other  -.601 .197  -.876 .077  -.907 .097 
Support apart from study Unknown  -1.35 .126  -1.29 .143  -1.93 .051 
 Support  .167 .675  .309 .455  .126 .789 
Group sEBT intervention  -.004 .989  .170 .587  .228 .512 
Time of investigation t3  .444 .029  .422 .053  .476 .044 
 t4  .574 .146  .807 .056  .761 .092 
Patient’s time of death Unknown  .366 .571  .313 .647  .278 .691 
 Alive  -.049 .862  -.147 .620  .063 .845 
 Deceased >3 months  .856 .032  .543 .195  .795 .073 
Age   .014 .424  .024 .182  .017 .373 
Psychologist Psychologist 1  .095 .826  .234 .598  .014 .977 
 Psychologist 2  -.091 .825  -.039 .927  -.378 .418 
Quality of Life (numerical rating scale) at t1   .206 .004  .187 .012  .167 .042 
 
Table 12: Estimated regression coefficients beta and p-values for the independent variables in general linear mixed models with 
the secondary outcome variable post-treatment quality of life (numerical rating scale). Main model: participants of at least the 
first two investigations (model 1); both sensitivity analyses include participants of at least the first two investigations, model 2 
without participants (sEBT and control group) with only one session, model 3 without participants of the sEBT group who did not 
practise. 
a Variables are in bold or bold italics depending on the significance of the F-test for the whole variable. Bold: significant at p-
value<0.05. Bold italics: p-value between 0.05 and 0.10 (trend). 
b Reference categories: Gender – Female; Relationship with Patient – Other; Employment – Employment/Student; Support apart 
from study – No support; Group – Control; Time of investigation – t2; Patient deceased – Deceased ≤ 3 months; Psychologist – 
Psychologist 3. 




















   Model 1  Model 2  Model 3 
Variable a Category b  n= 126  n= 114  n= 104 
   beta p-Value  beta p-Value  beta p-Value 
Gender Male  -.255 .469  -.141 .699  -.262 .509 
Relationship with patient  Partner/child  .468 .223  .712 .075  .299 .494 
Employment Retired/other  .628 .231  .369 .507  .691 .266 
Support apart from study Unknown  .593 .550  .392 .689  .432 .699 
 Support  -.156 .733  -.256 .582  -.183 .731 
Group sEBT intervention  .006 .986  .028 .935  -.059 .881 
Time of investigation t3  .049 .852  .005 .987  .107 .709 
 t4  .728 .171  .548 .327  .526 .364 
Patient’s time of death Unknown  .316 .667  .522 .497  .612 .442 
 Alive  -.272 .403  -.439 .205  -.269 .458 
 Deceased >3 months  -.889 .100  -.860 .130  -.795 .169 
Age   -.011 .574  -.016 .423  -.001 .980 
Psychologist Psychologist 1  -.770 .125  -.868 .083  -.775 .156 
 Psychologist 2  -.146 .756  -.214 .655  .006 .991 
Physical impairment at t1   .518 <.001  .543 <.001  .517 <.001 
 
Table 13: Estimated regression coefficients beta and p-values for the independent variables in general linear mixed models with 
the secondary outcome variable post-treatment physical impairment. Main model: participants of at least the first two 
investigations (model 1); both sensitivity analyses include participants of at least the first two investigations, model 2 without 
participants (sEBT and control group) with only one session, model 3 without participants of the sEBT group who did not 
practise. 
a Variables are in bold or bold italics depending on the significance of the F-test for the whole variable. Bold: significant at p-
value<0.05. Bold italics: p-value between 0.05 and 0.10 (trend). 
b Reference categories: Gender – Female; Relationship with Patient – Other; Employment – Employment/Student; Support apart 
from study – No support; Group – Control; Time of investigation – t2; Patient deceased – Deceased ≤ 3 months; Psychologist – 
Psychologist 3. 
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     Model 1  Model 2  Model 3 
Variable a Category b  n= 126  n= 114  n= 104 
   beta p-Value  beta p-Value  beta p-Value 
Gender Male  -.613 .092  -.350 .362  -.475 .251 
Relationship with patient  Partner/child  .402 .312  .509 .228  .240 .594 
Employment Retired/other  .445 .415  .613 .288  1.01 .118 
Support apart from study Unknown  .438 .666  .305 .764  1.26 .276 
 Support  .144 .757  -.068 .889  .078 .888 
Group sEBT intervention  -.846 .040  -.934 .029  -.900 .064 
Time of investigation t3  2.15 .146  2.21 .170  2.09 .194 
 t4  -1.72 .005  -2.11 .001  -2.08 .002 
Time of 
investigation*Group 
t3 * sEBT  -2.39 .265  -2.47 .295  -2.30 .386 
 t4 * sEBT  1.14 .025  .938 .075  .613 .286 
Patient’s time of death Unknow  1.83 .021  1.74 .040  1.80 .039 
 Alive  .615 .120  .484 .236  .507 .254 
 Deceased >3 months  -.456 .467  -.118 .860  -.072 .918 
Age   -.010 .604  -.023 .277  -.028 .209 
Psychologist Psychologist 1  -.460 .373  -.540 .304  -.512 .374 
 Psychologist 2  .346 .472  .290 .560  .723 .189 
Psychological impairment at t1   .446 <.001  .440 <.001  .418 <.001 
 
Table 14: Estimated regression coefficients beta and p-values for the independent variables in general linear mixed models with the 
secondary outcome variable post-treatment psychological impairment. Main model: participants of at least the first two investigations 
(model 1); both sensitivity analyses include participants of at least the first two investigations, model 2 without participants (sEBT and 
control group) with only one session, model 3 without participants of the sEBT group who did not practise. 
a Variables are in bold or bold italics depending on the significance of the F-test for the whole variable. Bold: significant at p-
value<0.05. Bold italics: p-value between 0.05 and 0.10 (trend). 
b Reference categories: Gender – Female; Relationship with Patient – Other; Employment – Employment/Student; Support apart from 
study – No support; Group – Control; Time of investigation – t2; Time of investigation*Group – t2*sEBT, t2*Control, t3*Control, 
t4*Control; Patient deceased – Deceased ≤ 3 months; Psychologist – Psychologist 3. 
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Appendix 2.3 Results of sensitivity analyses regarding missing data 
  
   Model 1  Model 2  Model 3 
Variable a Category b  n= 126  n= 114  n= 104 
   beta p-Value  beta p-Value  beta p-Value 
Gender Male  -.468 .396  -.323 .593  -.585 .328 
Relationship with patient  Partner/child  -.898 .172  -.799 .266  -1.12 .116 
Employment Retired/other  -.716 .396  -.365 .691  .410 .661 
Support apart from study Unknown  1.39 .371  1.30 .417  2.01 .232 
 Support  .701 .331  .503 .516  .857 .287 
Group sEBT intervention  -.174 .741  -.253 .666  -.387 .522 
Time of investigation t3  -.806 .029  -.966 .015  -.989 .020 
 t4  -1.35 .078  -1.75 .034  -1.78 .032 
Patients’ time of death Unknown  .350 .764  .073 .955  -.041 .973 
 Alivea  -.406 .391  -.514 .312  -.633 .238 
 Deceased >3 months  -.991 .196  -.878 .281  -.858 .290 
Age   .026 .417  .014 .679  -.005 .884 
Psychologist Psychologist 1  -.166 .833  -.269 .745  -.551 .500 
 Psychologist 2  .448 .547  .312 .695  .654 .423 
Missing data No missing data  -.615 .303  -.647 .324  -.611 .333 
Depression at t1  .619 <.001  .630 <.001  .603 <.001 
 
Table 15. Sensitivity analyses regarding missing data: Estimated regression coefficients beta and p-values for the independent 
variables in general linear mixed models with the primary outcome variable post-treatment depression. Main model: participants 
of at least the first two investigations (model 1); both sensitivity analyses include participants of at least the first two 
investigations, model 2 without participants (sEBT and control group) with only one session, model 3 without participants of the 
sEBT group who did not practise. 
a Variables are in bold or bold italics depending on the significance of the F-test for the whole variable. Bold: significant at p-
value<0.05. Bold italics: p-value between 0.05 and 0.10 (trend). 
b Reference categories: Gender – Female; Relationship with Patient – Other; Employment – Employment/Student; Support apart 
from study – No support; Group – Control; Time of investigation – t2; Patient deceased – Deceased≤3 months; Psychologist – 
Psychologist; Missing data – Missing data in outcome scales. 




















   Model 1  Model 2  Model 3 
Variable a Category b  n= 126  n= 114  n= 104 
   beta p-Value  beta p-Value  beta p-Value 
Gender Male  -.797 .176  -.595 .357  -.810 .217 
Relationship with patient  Partner/child  -.230 .9736  -.144 .847  -.480 .523 
Employment Retired/other  .042 .963  .303 .755  1.19 .241 
Support apart from study Unknown  1.75 .292  1.85 .285  2.74 .135 
 Support  .500 .514  .554 .501  .911 .300 
Group sEBT intervention  -.351 .530  -.564 .361  -.915 .162 
Time of investigation t3  -1.22 .003  -1.24 .006  -1.41 .002 
 t4  -1.70 .020  -1.77 .025  -2.27 .005 
Patient’s time of death Unknown  .637 .611  .281 .838  .091 .947 
 Alive  -.017 .974  .086 .881  -.459 .441 
 Deceased >3 months  -1.52 .033  -1.56 .042  -1.24 .108 
Age   -.005 .876  -.015 .676  -.039 .284 
Psychologist  Psychologist 1  -.108 .993  .042 .962  -.278 .754 
 Psychologist 2  -.510 .512  -.568 .496  -.408 .638 
Missing data No missing data  -.679 .286  -.628 .370  -.699 .311 
Anxiety at t1  .574 <.001  .553 <.001  .512 <.001 
 
Table 16. Sensitivity analyses regarding missing data: Estimated regression coefficients beta and p-values for the independent 
variables in general linear mixed models with the secondary outcome variable post-treatment anxiety. Main model: participants 
of at least the first two investigations (model 1); both sensitivity analyses include participants of at least the first two 
investigations, model 2 without participants (sEBT and control group) with only one session, model 3 without participants of the 
sEBT group who did not practise. 
a Variables are in bold or bold italics depending on the significance of the F-test for the whole variable. Bold: significant at p-
value<0.05. Bold italics: p-value between 0.05 and 0.10 (trend). 
b Reference categories: Gender – Female; Relationship with Patient – Other; Employment – Employment/Student; Support apart 
from study – No support; Group – Control; Time of investigation – t2; Patient deceased – Deceased ≤ 3 months;  Psychologist – 
Psychologist; Missing data – Missing data in outcome scales. 



















   Model 1  Model 2  Model 3 
Variable a Category b  n= 124  n= 112  n= 102 
   beta p-Value  beta p-Value  beta p-Value 
Gender Male  .311 .333  .486 .143  .370 .298 
Relationship with patient  Partner/child  .443 .242  .700 .074  .245 .553 
Employment Retired/other  .256 .591  .441 .366  .865 .110 
Support apart from study Unknown  -.311 .731  -.494 .574  .619 .529 
 Support  .449 .278  .223 .592  .700 .138 
Group sEBT intervention  -.020 .948  -.202 .529  -.078 .829 
Time of investigation t3  -.345 .153  -.450 .081  -.443 .115 
 t4  -.852 .107  -1.03 .067  -.938 .098 
Patient’s time of death Unknown  .293 .666  -.093 .894  -.073 .919 
 Alivea  .416 .185  .266 .416  .291 .417 
 Deceased >3 months  -1.12 .034  -1.01 .070  -1.12 .057 
Age   -.034 .060  -.044 .014  -.051 .008 
Psychologist Psychologist 1  -.432 .334  -.620 .160  -.676 .155 
 Psychologist 2  -.012 .978  -.100 .827  -.088 .858 
Missing data No missing data  -.190 .583  -.143 .689  -.203 .584 
Subjective distress at t1  .410 <.001  .391 <.001  .456 <.001 
 
Table 17. Sensitivity analyses regarding missing data: Estimated regression coefficients beta and p-values for the independent 
variables in general linear mixed models with the secondary outcome variable post-treatment subjective distress. Main model: 
participants of at least the first two investigations (model 1); both sensitivity analyses include participants of at least the first two 
investigations, model 2 without participants (sEBT and control group) with only one session, model 3 without participants of the 
sEBT group who did not practise. 
a Variables are in bold or bold italics depending on the significance of the F-test for the whole variable. Bold: significant at p-
value<0.05. Bold italics: p-value between 0.05 and 0.10 (trend). 
b Reference categories: Gender – Female; Relationship with Patient – Other; Employment – Employment/Student; Support apart 
from study – No support; Group – Control; Time of investigation – t2; Patient deceased – Deceased ≤ 3 months; Psychologist – 
Psychologist 3; Missing data – Missing data in outcome scales. 




















   Model 1  Model 2  Model 3 
Variable a Category b  n= 122  n= 110  n= 100 
   beta p-Value  beta p-Value  beta p-Value 
Gender Male  -.046 .592  -.127 .158  -.102 .289 
Relationship with patient  Partner/child  -.074 .448  -.146 .160  .024 .826 
Employment Retired/other  -.064 .611  -.109 .409  -.159 .276 
Support apart from study Unknown  -.188 .419  -.168 .464  -.225 .391 
 Support  .086 .445  .146 .215  .178 .182 
Group sEBT intervention  .022 .788  .044 .600  .065 .495 
Time of investigation t3  .159 .003  .173 .003  .211 .000 
 t4  .293 .031  .321 .024  .360 .016 
Patient’s time of death Unknown  .003 .987  .074 .685  .061 .747 
 Alive  .085 .241  .098 .199  .066 .405 
 Deceased >3 months  .107 .424  .042 .761  .103 .474 
Age   -.002 .651  .002 .706  -.001 .821 
Psychologist Psychologist 1  .065 .585  .092 .440  .079 .537 
 Psychologist 2  .121 .298  .115 .332  .035 .788 
Missing data No missing data  .052 .565  .080 .400  .103 .305 
Positive affect at t1   .681 <.001  .644 <.001  .692 <.001 
 
Table 18. Sensitivity analyses regarding missing data: Estimated regression coefficients beta and p-values for the independent 
variables in general linear mixed models with the secondary outcome variable post-treatment of positive affect. Main model: 
participants of at least the first two investigations (model 1); both sensitivity analyses include participants of at least the first two 
investigations, model 2 without participants (sEBT and control group) with only one session, model 3 without participants of the 
sEBT group who did not practise. 
a Variables are in bold or bold italics depending on the significance of the F-test for the whole variable. Bold: significant at p-
value<0.05. Bold italics: p-value between 0.05 and 0.10 (trend). 
b Reference categories: Gender – Female; Relationship with Patient – Other; Employment – Employment/Student; Support apart 
from study – No support; Group – Control; Time of investigation – t2; Patient deceased – Deceased ≤ 3 months; Psychologist – 
Psychologist 3; Missing data – Missing data in outcome scales. 




















   Model 1  Model 2  Model 3 
Variable a Category b  n= 122  n= 110  n= 100 
   beta p-Value  beta p-Value  beta p-Value 
Gender Male  .051 .520  .095 .273  .085 .325 
Relationship with patient  Partner/child  .067 .450  .103 .286  .009 .928 
Employment Retired/other  .125 .282  .145 .256  .276 .037 
Support apart from study Unknown  .211 .331  .200 .376  .351 .136 
 Support  -.048 .648  -.067 .551  .010 .936 
Group sEBT intervention  -.089 .233  -.079 .333  -.113 .188 
Time of investigation t3  -.130 .019  -.120 .046  -.122 .049 
 t4  -.175 .102  -.196 .096  -.182 .115 
Patient’s time of death Unknown  .032 .844  .037 .836  -.001 .997 
 Alive  -.074 .307  -.065 .411  -.088 .260 
 Deceased >3 months  -.281 .009  -.255 .030  -.270 .020 
Age   -.005 .258  -.006 .180  -.010 .042 
Psychologist Psychologist 1  -.126 .252  -.136 .239  -.185 .110 
 Psychologist 2  .033 .757  .057 .614  .103 .380 
Missing data No missing data  -.155 .064  -.177 .055  -.183 .042 
Negative affect at t1   .543 <.001  .563 <.001  .526 <.001 
 
Table 19. Sensitivity analyses regarding missing data: Estimated regression coefficients beta and p-values for the independent 
variables in general linear mixed models with the secondary outcome variable post-treatment negative affect.  Main model: 
participants of at least the first two investigations (model 1); both sensitivity analyses include participants of at least the first two 
investigations, model 2 without participants (sEBT and control group) with only one session, model 3 without participants of the 
sEBT group who did not practise. 
a Variables are in bold or bold italics depending on the significance of the F-test for the whole variable. Bold: significant at p-
value<0.05. Bold italics: p-value between 0.05 and 0.10 (trend). 
b Reference categories: Gender – Female; Relationship with Patient – Other; Employment – Employment/Student; Support apart 
from study – No support; Group – Control; Time of investigation – t2; Patient deceased – Deceased ≤ 3 months; Psychologist – 
Psychologist 3; Missing data – Missing data in outcome scales. 




















   Model 1  Model 2  Model 3 
Variable a Category b  n= 126  n= 114  n= 104 
   beta p-Value  beta p-Value  beta p-Value 
Gender Male  -.130 .854  .368 .614  .054 .945 
Relationship with patient Partner/child  .848 .309  1.30 .133  .397 .661 
Employment Retired/other  -1.6 .124  -1.09 .317  -.933 .441 
Support apart from study Unknown  1.87 .345  1.71 .375  3.07 .159 
 Support  .962 .295  .701 .452  .782 .453 
Group sEBT intervention  -.440 .512  -.640 .356  -.801 .307 
Time of investigation t3  -1.34 .008  -1.66 .002  -1.63 .006 
 t4  -3.03 .008  -3.38 .007  -3.60 .005 
Patient’s time of death Unknown  -1.26 .399  -2.13 .168  -1.94 .229 
 Alive  -.960 .146  -1.35 .050  -1.33 .078 
 Deceased >3 months  -1.40 .232  -1.19 .344  -1.28 .317 
Age   .032 .420  .002 .970  .015 .733 
Psychologist  Psychologist 1  .191 .847  .140 .887  -.319 .763 
 Psychologist 2  -.214 .821  -.306 .747  -.257 .807 
Missing data No missing data  -1.08 .158  -1.33 .095  -1.27 .125 
Minor mental disorders at t1   .612 <.001  .627 <.001  .598 <.001 
 
Table 20. Sensitivity analyses regarding missing data: Estimated regression coefficients beta and p-values for the independent 
variables in general linear mixed models with the secondary outcome variable post-treatment minor mental disorders. Main 
model: participants of at least the first two investigations (model 1); both sensitivity analyses include participants of at least the 
first two investigations, model 2 without participants (sEBT and control group) with only one session, model 3 without 
participants of the sEBT group who did not practise. 
a Variables are in bold or bold italics depending on the significance of the F-test for the whole variable. Bold: significant at p-
value<0.05. Bold italics: p-value between 0.05 and 0.10 (trend). 
b Reference categories: Gender – Female; Relationship with Patient – Other; Employment – Employment/Student; Support apart 
from study – No support; Group – Control; Time of investigation – t2; Patient deceased – Deceased ≤ 3 months; Psychologist – 
Psychologist 3; Missing data – Missing data in outcome scales. 



















   Model 1  Model 2  Model 3 
Variable a Category b  n= 126  n= 114  n= 104 
   beta p-Value  beta p-Value  beta p-Value 
Gender Male  -.088 .906  -.315 .693  .179 .822 
Relationship with patient  Partner/child  -.001 .999  .090 .992  .270 .769 
Employment Retired/other  -.548 .620  -.1.29 .276  -2.22 .072 
Support apart from study Unknown  -.002 .999  .175 .933  -2.60 .246 
 Support  -.491 .606  -.388 .698  -.569 .594 
Group sEBT intervention  -.095 .890  .063 .932  .682 .385 
Time of investigation t3  -.467 .237  -.310 .461  -.267 .553 
 t4  -.586 .495  -.342 .710  -.218 .820 
Patient’s time of death Unknown  -1.45 .341  -.989 .546  -.958 .550 
 Alive  -1.37 .015  -1.04 .081  -1.38 .032 
 Deceased >3 months  .960 .259  .719 .430  .908 .326 
Age   .012 .769  .034 .428  .038 .389 
Psychologist Psychologist 1  .379 .714  .407 .702  1.00 .352 
 Psychologist 2  -.106 .912  -.082 .935  -.521 .615 
Missing data No missing data  .658 .401  .707 .398  .581 .483 
Satisfaction with life at t1   .644 <.001  .662 <.001  .609 <.001 
 
Table 21. Sensitivity analyses regarding missing data: Estimated regression coefficients beta and p-values for the independent 
variables in general linear mixed models with the secondary outcome variable post-treatment satisfaction with life. Main model: 
participants of at least the first two investigations (model 1); both sensitivity analyses include participants of at least the first two 
investigations, model 2 without participants (sEBT and control group) with only one session, model 3 without participants of the 
sEBT group who did not practise. 
a Variables are in bold or bold italics depending on the significance of the F-test for the whole variable. Bold: significant at p-
value<0.05. Bold italics: p-value between 0.05 and 0.10 (trend). 
b Reference categories: Gender – Female; Relationship with Patient – Other; Employment – Employment/Student; Support apart 
from study – No support; Group – Control; Time of investigation – t2; Patient deceased – Deceased ≤ 3 months; Psychologist – 
Psychologist 3; Missing data – Missing data in outcome scales. 




















   Model 1  Model 2  Model 3 
Variable a Category b  n= 126  n= 114  n= 104 
   beta p-Value  beta p-Value  beta p-Value 
Gender Male  -4.09 .103  -5.75 .029  -3.93 .159 
Relationship with patient  Partner/child  -1.55 .593  -1.29 .668  -1.99 .538 
Employment Retired/other  1.81 .632  .186 .962  1.12 .798 
Support apart from study Unknown  -4.76 .510  -6.26 .375  -8.50 .289 
 Support  -.930 .775  -1.28 .699  -2.82 .454 
Group sEBT intervention  -2.20 .354  -1.12 .650  -3.17 .262 
Time of investigation t3  .830 .667  1.26 .509  2.13 .298 
 t4  -.852 .853  -.151 .974  -.528 .913 
Patient’s time of death Unknown  -1.10 .836  -.854 .876  -.303 .958 
 Alive  .168 .947  1.35 .592  .593 .827 
 Deceased >3 months  4.81 .309  5.50 .249  5.98 .219 
Age   -.143 .322  -.129 .372  -.136 .400 
Psychologist Psychologist 1  -1.63 .646  -2.79 .432  -.999 .794 
 Psychologist 2  -2.99 .372  -3.12 .356  -1.92 .607 
Missing data No missing data  -.701 .792  -1.27 .645  -1.38 .637 
Quality of life (World Health Organisation) at 
t1 
 .452 <.001  .519 <.001  .471 <.001 
 
Table 22. Sensitivity analyses regarding missing data: Estimated regression coefficients beta and p-values for the independent 
variables in general linear mixed models with the secondary outcome variable post-treatment quality of life (World Health 
Organisation). Main model: participants of at least the first two investigations (model 1); both sensitivity analyses include 
participants of at least the first two investigations, model 2 without participants (sEBT and control group) with only one session, 
model 3 without participants of the sEBT group who did not practise. 
a Variables are in bold or bold italics depending on the significance of the F-test for the whole variable. Bold: significant at p-
value<0.05. Bold italics: p-value between 0.05 and 0.10 (trend). 
b Reference categories: Gender – Female; Relationship with Patient – Other; Employment – Employment/Student; Support apart 
from study – No support; Group – Control; Time of investigation – t2; Patient deceased – Deceased ≤ 3 months; Psychologist – 
Psychologist 3; Missing data – Missing data in outcome scales. 




















   Model 1  Model 2  Model 3 
Variable a Category b  n= 123  n= 111  n= 102 
   beta p-Value  beta p-Value  beta p-Value 
Gender Male  -.421 .181  -.660 .051  -.412 .249 
Relationship with pat.  Partner/child  -.558 .123  -.735 .057  -.360 .377 
Employment Retired/other  -.569 .224  -.850 .088  -.880 .109 
Support apart from study Unknown  -1.32 .134  -1.27 .151  -1.90 .054 
 Support  .107 .790  .272 .518  .101 .839 
Group sEBT intervention  .008 .977  .163 .603  .226 .517 
Time of investigation t3  .448 .028  .424 .052  .477 .044 
 t4  .592 .134  .816 .053  .768 .090 
Patient’s time of death Unknown  .493 .453  .377 .588  .382 .593 
 Alive  -.37 .894  -.140 .638  .065 .842 
 Deceased >3 months  .836 .036  .533 .203  .784 .078 
Age   .014 .405  .024 .177  .017 .363 
Psychologist Psychologist 1  .052 .906  .205 .646  -.006 .991 
 Psychologist 2  -.093 .821  -.050 .908  -.382 .414 
Missing data No missing data  .354 .290  .203 .507  .290 .436 
Quality of Life (numerical rating scale) at t1   .215 .003  .195 .010  .178 .033 
 
Table 23: Sensitivity analyses regarding missing data: Estimated regression coefficients beta and p-values for the independent 
variables in general linear mixed models with the secondary outcome variable post-treatment quality of life (numerical rating 
scale). Main model: participants of at least the first two investigations (model 1); both sensitivity analyses include participants of 
at least the first two investigations, model 2 without participants (sEBT and control group) with only one session, model 3 
without participants of the sEBT group who did not practise. 
a Variables are in bold or bold italics depending on the significance of the F-test for the whole variable. Bold: significant at p-
value<0.05. Bold italics: p-value between 0.05 and 0.10 (trend). 
b Reference categories: Gender – Female; Relationship with Patient – Other; Employment – Employment/Student; Support apart 
from study – No support; Group – Control; Time of investigation – t2; Patient deceased – Deceased ≤ 3 months; Psychologist – 
Psychologist 3; Missing data – Missing data in outcome scales. 



















    
   Model 1  Model 2  Model 3 
Variable a Category b  n= 126  n= 114  n= 104 
   beta p-Value  beta p-Value  beta p-Value 
Gender Male  -.260 .460  -.161 .658  -.260 .514 
Relationship with patient  Partner/child  .347 .391  .518 .212  .195 .673 
Employment Retired/other  .593 .274  .249 .655  .643 .304 
Support apart from study Unknown  .571 .566  .346 .722  .428 .703 
 Support  -.097 .834  -.134 .774  -.148 .781 
Group sEBT intervention  -.023 .946  .036 .917  -.063 .874 
Time of investigation t3  .045 .862  .000 1.00  .105 .713 
 t4  .717 .178  .532 .341  .520 .370 
Patient’s time of death Unknown  .206 .783  .354 .648  .105 .530 
 Alive  -.283 .386  -.456 .189  -.273 .453 
 Deceased >3 months  -.878 .104  -.844 .136  -.789 .172 
Age   -.011 .593  -.015 .442  -.002 .994 
Psychologist Psychologist 1  -.710 .160  -.756 .132  -.775 .180 
 Psychologist 2  -.150 .751  -.200 .674  -.001 .999 
Missing data No missing data  -.346 .366  -.580 .144  -.299 .483 
Physical impairment at t1   .524 <.001  .557 <.001  .525 <.001 
 
Table 24. Sensitivity analyses regarding missing data: Estimated regression coefficients beta and p-values for the independent 
variables in general linear mixed models with the secondary outcome variable post-treatment physical impairment. Main model: 
participants of at least the first two investigations (model 1); both sensitivity analyses include participants of at least the first two 
investigations, model 2 without participants (sEBT and control group) with only one session, model 3 without participants of the 
sEBT group who did not practise. 
a Variables are in bold or bold italics depending on the significance of the F-test for the whole variable. Bold: significant at p-
value<0.05. Bold italics: p-value between 0.05 and 0.10 (trend). 
b Reference categories: Gender – Female; Relationship with Patient – Other; Employment – Employment/Student; Support apart 
from study – No support; Group – Control; Time of investigation – t2; Patient deceased – Deceased ≤ 3 months; Psychologist – 
Psychologist 3; Missing data – Missing data in outcome scales. 






   Model 1  Model 2  Model 3 
Variable a Category b  n= 126  n= 114  n= 104 
   beta p-Value  beta p-Value  beta p-Value 
Gender Male   -.630 .081  -.384 .312  -.481 .240 
Relationship with patient  Partner/child   .197 .635  .280 .522  -.001 .998 
Employment Retired/other   .400 .460  .543 .342  .955 .133 
Support apart from study Unknown   .435 .666  .303 .763  1.27 .266 
 Support   .255 .586  .080 .869  .158 .733 
Group sEBT intervention   -.881 .033  -.924 .031  -.903 .063 
Time of investigation t3   2.14 .148  2.20 .172  2.09 .196 
 t4  -1.77 .004  -2.14 .001  -2.12 .002 
Time of 
investigation*Group 
t3 * sEBT   -2.39 .266  -2.47 .296  -2.30 .386 
 t4 * sEBT   1.15 .024  .954 .070  .616 .283 
Patient’s time of death Unknown   1.61 .044  1.53 .072  1.53 .081 
 Alive   .584 .142  .454 .268  .488 .272 
 Deceased >3 months  -.414 .507  -.096 .886  -.040 .954 
Age   -.011 .578  -.023 .254  -.029 .188 
Psychologist Psychologist 1   -.396 .441  -.466 .373  -.469 .411 
 Psychologist 2   .327 .494  .295 .550  .702 .197 
Missing data No missing data  -.626 .106  -.697 .090  -.750 .081 
Psychological impairment at t1   .454 <.001  .456 <.001  .430 <.001 
 
Table 25. Sensitivity analyses regarding missing data: Estimated regression coefficients beta and p-values for the independent 
variables in general linear mixed models with the secondary outcome variable post-treatment psychological impairment. Main model: 
participants of at least the first two investigations (model 1); both sensitivity analyses include participants of at least the first two 
investigations, model 2 without participants (sEBT and control group) with only one session, model 3 without participants of the sEBT 
group who did not practise. 
a Variables are in bold or bold italics depending on the significance of the F-test for the whole variable. Bold: significant at p-
value<0.05.  Bold italics: p-value between 0.05 and 0.10 (trend). 
b Reference categories: Gender – Female; Relationship with Patient – Other; Employment – Employment/Student; Support apart from 
study – No support; Group – Control; Time of investigation – t2; Time of investigation*Group – t2*sEBT, t2*Control, t3*Control, 
t4*Control; Patient deceased – Deceased ≤ 3 months; Psychologist – Psychologist 3; Missing data – Missing data in outcome scales. 
